false 0000802481 12/28 Q1 2025 http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet xbrli:shares iso4217:USD iso4217:USD xbrli:shares ppc:country ppc:employee ppc:bird ppc:grower ppc:pig xbrli:pure iso4217:GBP iso4217:MXN ppc:plan ppc:segment 0000802481 2024-12-30 2025-03-30 0000802481 2025-04-30 0000802481 2025-03-30 0000802481 2024-12-29 0000802481 us-gaap:NonrelatedPartyMember 2025-03-30 0000802481 us-gaap:NonrelatedPartyMember 2024-12-29 0000802481 us-gaap:RelatedPartyMember 2025-03-30 0000802481 us-gaap:RelatedPartyMember 2024-12-29 0000802481 2024-01-01 2024-03-31 0000802481 us-gaap:CommonStockMember 2024-12-29 0000802481 us-gaap:TreasuryStockCommonMember 2024-12-29 0000802481 us-gaap:AdditionalPaidInCapitalMember 2024-12-29 0000802481 us-gaap:RetainedEarningsMember 2024-12-29 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-29 0000802481 us-gaap:NoncontrollingInterestMember 2024-12-29 0000802481 us-gaap:RetainedEarningsMember 2024-12-30 2025-03-30 0000802481 us-gaap:NoncontrollingInterestMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-30 2025-03-30 0000802481 us-gaap:CommonStockMember 2024-12-30 2025-03-30 0000802481 us-gaap:AdditionalPaidInCapitalMember 2024-12-30 2025-03-30 0000802481 us-gaap:CommonStockMember 2025-03-30 0000802481 us-gaap:TreasuryStockCommonMember 2025-03-30 0000802481 us-gaap:AdditionalPaidInCapitalMember 2025-03-30 0000802481 us-gaap:RetainedEarningsMember 2025-03-30 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-30 0000802481 us-gaap:NoncontrollingInterestMember 2025-03-30 0000802481 us-gaap:CommonStockMember 2023-12-31 0000802481 us-gaap:TreasuryStockCommonMember 2023-12-31 0000802481 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000802481 us-gaap:RetainedEarningsMember 2023-12-31 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000802481 us-gaap:NoncontrollingInterestMember 2023-12-31 0000802481 2023-12-31 0000802481 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000802481 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000802481 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000802481 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000802481 us-gaap:CommonStockMember 2024-03-31 0000802481 us-gaap:TreasuryStockCommonMember 2024-03-31 0000802481 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000802481 us-gaap:RetainedEarningsMember 2024-03-31 0000802481 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000802481 us-gaap:NoncontrollingInterestMember 2024-03-31 0000802481 2024-03-31 0000802481 ppc:ChickenMember 2025-03-30 0000802481 ppc:PorkMember 2025-03-30 0000802481 ppc:PilgrimsPrideCorporationMember ppc:JBSSAMember 2024-12-30 2025-03-30 0000802481 ppc:FreshProductMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:PreparedProductMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherProductAndServiceMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FreshProductMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:PreparedProductMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherProductAndServiceMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FreshProductMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:PreparedProductMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherProductAndServiceMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FreshProductMember 2024-12-30 2025-03-30 0000802481 ppc:PreparedProductMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember 2024-12-30 2025-03-30 0000802481 ppc:OtherProductAndServiceMember 2024-12-30 2025-03-30 0000802481 ppc:FreshProductMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:PreparedProductMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherProductAndServiceMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FreshProductMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:PreparedProductMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherProductAndServiceMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FreshProductMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:PreparedProductMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherProductAndServiceMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FreshProductMember 2024-01-01 2024-03-31 0000802481 ppc:PreparedProductMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember 2024-01-01 2024-03-31 0000802481 ppc:OtherProductAndServiceMember 2024-01-01 2024-03-31 0000802481 us-gaap:RetailMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FoodServiceMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherSalesChannelMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:RetailMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FoodServiceMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherSalesChannelMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:RetailMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:FoodServiceMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:OtherSalesChannelMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:RetailMember 2024-12-30 2025-03-30 0000802481 ppc:FoodServiceMember 2024-12-30 2025-03-30 0000802481 ppc:ProductExportMember 2024-12-30 2025-03-30 0000802481 ppc:OtherSalesChannelMember 2024-12-30 2025-03-30 0000802481 us-gaap:RetailMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FoodServiceMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherSalesChannelMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:RetailMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FoodServiceMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherSalesChannelMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:RetailMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:FoodServiceMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 ppc:OtherSalesChannelMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:RetailMember 2024-01-01 2024-03-31 0000802481 ppc:FoodServiceMember 2024-01-01 2024-03-31 0000802481 ppc:ProductExportMember 2024-01-01 2024-03-31 0000802481 ppc:OtherSalesChannelMember 2024-01-01 2024-03-31 0000802481 srt:MinimumMember 2024-12-30 2025-03-30 0000802481 srt:MaximumMember 2024-12-30 2025-03-30 0000802481 us-gaap:CommodityContractMember 2025-03-30 0000802481 us-gaap:CommodityContractMember 2024-12-29 0000802481 us-gaap:ForeignExchangeForwardMember 2025-03-30 0000802481 us-gaap:ForeignExchangeForwardMember 2024-12-29 0000802481 ppc:SalesContractDerivativeAssetsMember 2025-03-30 0000802481 ppc:SalesContractDerivativeAssetsMember 2024-12-29 0000802481 ppc:SalesContractDerivativeMember 2025-03-30 0000802481 ppc:SalesContractDerivativeMember 2024-12-29 0000802481 ppc:CornMember 2024-12-30 2025-03-30 0000802481 ppc:CornMember 2024-01-01 2024-12-29 0000802481 ppc:SoybeanMealMember 2024-12-30 2025-03-30 0000802481 ppc:SoybeanMealMember 2024-01-01 2024-12-29 0000802481 us-gaap:CommodityContractMember 2024-12-30 2025-03-30 0000802481 us-gaap:CommodityContractMember 2024-01-01 2024-03-31 0000802481 ppc:SalesContractDerivativeMember 2024-12-30 2025-03-30 0000802481 ppc:SalesContractDerivativeMember 2024-01-01 2024-03-31 0000802481 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-12-30 2025-03-30 0000802481 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000802481 ppc:NetSalesMember ppc:SalesContractDerivativeMember 2024-12-30 2025-03-30 0000802481 ppc:CostOfGoodsSoldMember us-gaap:CommodityContractMember 2024-12-30 2025-03-30 0000802481 ppc:NetSalesMember ppc:SalesContractDerivativeMember 2024-01-01 2024-03-31 0000802481 ppc:CostOfGoodsSoldMember us-gaap:CommodityContractMember 2024-01-01 2024-03-31 0000802481 ppc:NetSalesMember us-gaap:ForeignExchangeContractMember 2024-12-30 2025-03-30 0000802481 ppc:CostOfGoodsSoldMember us-gaap:ForeignExchangeContractMember 2024-12-30 2025-03-30 0000802481 ppc:NetSalesMember us-gaap:ForeignExchangeContractMember 2024-01-01 2024-03-31 0000802481 ppc:CostOfGoodsSoldMember us-gaap:ForeignExchangeContractMember 2024-01-01 2024-03-31 0000802481 us-gaap:ForeignExchangeForwardMember 2024-12-30 2025-03-30 0000802481 ppc:JBSUSAFoodCompanyMember 2023-06-30 0000802481 us-gaap:CashEquivalentsMember 2025-03-30 0000802481 us-gaap:CashEquivalentsMember 2024-12-29 0000802481 us-gaap:ShortTermInvestmentsMember 2025-03-30 0000802481 us-gaap:ShortTermInvestmentsMember 2024-12-29 0000802481 ppc:USReportableSegmentMember 2024-12-29 0000802481 ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:USReportableSegmentMember 2025-03-30 0000802481 ppc:EuropeReportableSegmentMember 2024-12-29 0000802481 ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:EuropeReportableSegmentMember 2025-03-30 0000802481 ppc:MexicoReportableSegmentMember 2024-12-29 0000802481 ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 ppc:MexicoReportableSegmentMember 2025-03-30 0000802481 us-gaap:TradeNamesMember 2024-12-29 0000802481 us-gaap:TradeNamesMember 2024-12-30 2025-03-30 0000802481 us-gaap:TradeNamesMember 2025-03-30 0000802481 us-gaap:TradeNamesMember 2024-12-29 0000802481 us-gaap:TradeNamesMember 2024-12-30 2025-03-30 0000802481 us-gaap:TradeNamesMember 2025-03-30 0000802481 us-gaap:CustomerRelationshipsMember 2024-12-29 0000802481 us-gaap:CustomerRelationshipsMember 2024-12-30 2025-03-30 0000802481 us-gaap:CustomerRelationshipsMember 2025-03-30 0000802481 us-gaap:CustomerRelationshipsMember srt:MinimumMember 2025-03-30 0000802481 us-gaap:CustomerRelationshipsMember srt:MaximumMember 2025-03-30 0000802481 us-gaap:TradeNamesMember srt:MinimumMember 2025-03-30 0000802481 us-gaap:TradeNamesMember srt:MaximumMember 2025-03-30 0000802481 us-gaap:LandMember 2025-03-30 0000802481 us-gaap:LandMember 2024-12-29 0000802481 us-gaap:BuildingMember 2025-03-30 0000802481 us-gaap:BuildingMember 2024-12-29 0000802481 us-gaap:MachineryAndEquipmentMember 2025-03-30 0000802481 us-gaap:MachineryAndEquipmentMember 2024-12-29 0000802481 us-gaap:VehiclesMember 2025-03-30 0000802481 us-gaap:VehiclesMember 2024-12-29 0000802481 us-gaap:ConstructionInProgressMember 2025-03-30 0000802481 us-gaap:ConstructionInProgressMember 2024-12-29 0000802481 2024-01-01 2024-12-29 0000802481 srt:MinimumMember 2025-03-30 0000802481 srt:MaximumMember 2025-03-30 0000802481 ppc:SeniorNotes6.875Due2034Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:SeniorNotes6.875Due2034Member us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:SeniorNotes6.250Due2033Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:SeniorNotes6.250Due2033Member us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:SeniorNotes350Due2032Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:SeniorNotes350Due2032Member us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:SeniorNotes4.25Due2031Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:SeniorNotes4.25Due2031Member us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:USRevolvingCreditFacilityDue2028Member us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-12-30 2025-03-30 0000802481 ppc:USRevolvingCreditFacilityDue2028Member us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-03-30 0000802481 ppc:USRevolvingCreditFacilityDue2028Member us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-12-29 0000802481 ppc:EuropeCreditFacilityDue2027Member us-gaap:LineOfCreditMember ppc:SterlingOvernightIndexAverageRateMember 2024-12-30 2025-03-30 0000802481 ppc:EuropeCreditFacilityDue2027Member us-gaap:LineOfCreditMember ppc:SterlingOvernightIndexAverageRateMember 2025-03-30 0000802481 ppc:EuropeCreditFacilityDue2027Member us-gaap:LineOfCreditMember ppc:SterlingOvernightIndexAverageRateMember 2024-12-29 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember ppc:TIIERateMember 2024-12-30 2025-03-30 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember ppc:TIIERateMember 2025-03-30 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember ppc:TIIERateMember 2024-12-29 0000802481 ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:LiveOakCHPProjectPaceLoan5.15PercentMember 2025-03-30 0000802481 ppc:LiveOakCHPProjectPaceLoan5.15PercentMember 2024-12-29 0000802481 ppc:BondRepurchaseProgramSeniorNotesDue2031Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:BondRepurchaseProgramSeniorNotesDue2033Member us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:BondRepurchaseProgramMember us-gaap:SeniorNotesMember 2024-12-30 2025-03-30 0000802481 ppc:BondRepurchaseProgramSeniorNotesDue2031Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2025-04-30 0000802481 ppc:BondRepurchaseProgramSeniorNotesDue2033Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2025-04-30 0000802481 ppc:A2021USCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-10-04 0000802481 ppc:A2021USCreditFacilityMember us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:A2021USCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:A2021USCreditFacilityMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:MoyParkBankOfIrelandRevolvingFacilityMember us-gaap:LineOfCreditMember 2022-06-24 0000802481 ppc:BankOfIrelandRevolvingFacilityDue2023Member us-gaap:LineOfCreditMember ppc:SterlingOvernightIndexAverageRateMember 2022-06-24 2022-06-24 0000802481 ppc:BankOfIrelandRevolvingFacilityDue2023Member us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:UKAndEuropeRevolvingFacilityMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LineOfCreditMember 2023-08-15 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LineOfCreditMember ppc:TIIERateMember 2023-08-15 2023-08-15 0000802481 ppc:MexicoCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 ppc:MexicoBBVACreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LineOfCreditMember 2025-03-30 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-29 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-29 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-29 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-29 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-30 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-30 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-03-30 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-03-30 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-12-31 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-12-31 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-03-31 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-03-31 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-30 2025-03-30 0000802481 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000802481 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-30 2025-03-30 0000802481 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000802481 2025-03-13 2025-03-13 0000802481 us-gaap:SubsequentEventMember 2025-04-17 2025-04-17 0000802481 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-12-29 0000802481 us-gaap:PensionPlansDefinedBenefitMember 2024-12-30 2025-03-30 0000802481 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-12-30 2025-03-30 0000802481 us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-03-31 0000802481 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-01 2024-03-31 0000802481 us-gaap:PensionPlansDefinedBenefitMember 2025-03-30 0000802481 country:US 2024-12-30 2025-03-30 0000802481 country:MX 2024-12-30 2025-03-30 0000802481 srt:EuropeMember 2024-12-30 2025-03-30 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeForwardMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeForwardMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel1Member ppc:SalesContractDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SalesContractDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-30 0000802481 us-gaap:FairValueMeasurementsRecurringMember ppc:SalesContractDerivativeMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel1Member ppc:SalesContractDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SalesContractDerivativeMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-29 0000802481 us-gaap:FairValueMeasurementsRecurringMember ppc:SalesContractDerivativeMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes350Due2032Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes350Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes350Due2032Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes350Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes4.25Due2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes4.25Due2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes4.25Due2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:SeniorNotes4.25Due2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt625AtLevel2InputsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel2Member ppc:FixedRateSeniorNotesPayableAt6.875AtLevel2InputsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel3Member ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel3Member ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-03-30 0000802481 us-gaap:FairValueInputsLevel3Member ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 us-gaap:FairValueInputsLevel3Member ppc:LiveOakCHPProjectPaceLoan5.15PercentMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-12-29 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:EmployeeRelatedCostsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:EmployeeRelatedCostsMember 2024-12-30 2025-03-30 0000802481 ppc:EmployeeRelatedCostsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:AssetImpairmentsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:AssetImpairmentsMember 2024-12-30 2025-03-30 0000802481 ppc:AssetImpairmentsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member us-gaap:ContractTerminationMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember us-gaap:ContractTerminationMember 2024-12-30 2025-03-30 0000802481 us-gaap:ContractTerminationMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:OtherExitAndDisposalCostsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:OtherExitAndDisposalCostsMember 2024-12-30 2025-03-30 0000802481 ppc:OtherExitAndDisposalCostsMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:EmployeeRelatedCostsMember 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:EmployeeRelatedCostsMember 2025-03-30 0000802481 ppc:EmployeeRelatedCostsMember 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:AssetImpairmentsMember 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:AssetImpairmentsMember 2025-03-30 0000802481 ppc:AssetImpairmentsMember 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member us-gaap:ContractTerminationMember 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember us-gaap:ContractTerminationMember 2025-03-30 0000802481 us-gaap:ContractTerminationMember 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member ppc:OtherExitAndDisposalCostsMember 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember ppc:OtherExitAndDisposalCostsMember 2025-03-30 0000802481 ppc:OtherExitAndDisposalCostsMember 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 ppc:PriorProgramsSubstantiallyCompleteMember 2024-12-30 2025-03-30 0000802481 ppc:EmployeeRetentionBenefitsMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 ppc:EmployeeRetentionBenefitsMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:EmployeeRetentionBenefitsMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 ppc:AssetImpairmentsMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 ppc:AssetImpairmentsMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:AssetImpairmentsMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member 2024-12-29 0000802481 ppc:PilgrimsFoodMasters2024Member 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsFoodMasters2024Member 2025-03-30 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 us-gaap:EmployeeSeveranceMember ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 ppc:InventoryAdjustmentMember ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 ppc:LeaseTerminationMember ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 us-gaap:OtherRestructuringMember ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 us-gaap:ContractTerminationMember ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 us-gaap:ContractTerminationMember ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 us-gaap:ContractTerminationMember ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember 2024-12-29 0000802481 ppc:PilgrimsEuropeCentralMember 2024-12-30 2025-03-30 0000802481 ppc:PilgrimsEuropeCentralMember 2025-03-30 0000802481 ppc:JBSToledoMember 2024-12-30 2025-03-30 0000802481 ppc:JBSToledoMember 2024-01-01 2024-03-31 0000802481 ppc:JBSUSAFoodCompanyMember 2024-12-30 2025-03-30 0000802481 ppc:JBSUSAFoodCompanyMember 2024-01-01 2024-03-31 0000802481 ppc:OtherRelatedPartyMember 2024-12-30 2025-03-30 0000802481 ppc:OtherRelatedPartyMember 2024-01-01 2024-03-31 0000802481 us-gaap:RelatedPartyMember 2024-12-30 2025-03-30 0000802481 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0000802481 ppc:SearaMeatsB.V.Member 2024-12-30 2025-03-30 0000802481 ppc:SearaMeatsB.V.Member 2024-01-01 2024-03-31 0000802481 ppc:PenasulUKLTDMember 2024-12-30 2025-03-30 0000802481 ppc:PenasulUKLTDMember 2024-01-01 2024-03-31 0000802481 ppc:JBSAsiaCoLimitedMember 2024-12-30 2025-03-30 0000802481 ppc:JBSAsiaCoLimitedMember 2024-01-01 2024-03-31 0000802481 ppc:JBSToledoMember 2025-03-30 0000802481 ppc:JBSToledoMember 2024-12-29 0000802481 ppc:JBSUSAFoodCompanyMember 2025-03-30 0000802481 ppc:JBSUSAFoodCompanyMember 2024-12-29 0000802481 ppc:JBSChileLtdMember 2025-03-30 0000802481 ppc:JBSChileLtdMember 2024-12-29 0000802481 ppc:OtherRelatedPartyMember 2025-03-30 0000802481 ppc:OtherRelatedPartyMember 2024-12-29 0000802481 ppc:SearaMeatsB.V.Member 2025-03-30 0000802481 ppc:SearaMeatsB.V.Member 2024-12-29 0000802481 ppc:JBSAsiaCoLimitedMember 2025-03-30 0000802481 ppc:JBSAsiaCoLimitedMember 2024-12-29 0000802481 us-gaap:IntersegmentEliminationMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:IntersegmentEliminationMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:OperatingSegmentsMember ppc:USReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:USReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:OperatingSegmentsMember ppc:EuropeReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:EuropeReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:OperatingSegmentsMember ppc:MexicoReportableSegmentMember 2024-12-30 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:MexicoReportableSegmentMember 2024-01-01 2024-03-31 0000802481 us-gaap:IntersegmentEliminationMember 2024-12-30 2025-03-30 0000802481 us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0000802481 us-gaap:OperatingSegmentsMember ppc:USReportableSegmentMember 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:USReportableSegmentMember 2024-12-29 0000802481 us-gaap:OperatingSegmentsMember ppc:EuropeReportableSegmentMember 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:EuropeReportableSegmentMember 2024-12-29 0000802481 us-gaap:OperatingSegmentsMember ppc:MexicoReportableSegmentMember 2025-03-30 0000802481 us-gaap:OperatingSegmentsMember ppc:MexicoReportableSegmentMember 2024-12-29 0000802481 us-gaap:IntersegmentEliminationMember 2025-03-30 0000802481 us-gaap:IntersegmentEliminationMember 2024-12-29 0000802481 country:US 2024-12-30 2025-03-30 0000802481 country:US 2024-01-01 2024-03-31 0000802481 srt:EuropeMember 2024-12-30 2025-03-30 0000802481 srt:EuropeMember 2024-01-01 2024-03-31 0000802481 country:MX 2024-12-30 2025-03-30 0000802481 country:MX 2024-01-01 2024-03-31 0000802481 srt:AsiaPacificMember 2024-12-30 2025-03-30 0000802481 srt:AsiaPacificMember 2024-01-01 2024-03-31 0000802481 ppc:CanadaCaribbeanandCentralAmericaMember 2024-12-30 2025-03-30 0000802481 ppc:CanadaCaribbeanandCentralAmericaMember 2024-01-01 2024-03-31 0000802481 srt:AfricaMember 2024-12-30 2025-03-30 0000802481 srt:AfricaMember 2024-01-01 2024-03-31 0000802481 srt:SouthAmericaMember 2024-12-30 2025-03-30 0000802481 srt:SouthAmericaMember 2024-01-01 2024-03-31 0000802481 ppc:BroilerChickenAntitrustLitigationMember us-gaap:SettledLitigationMember 2025-02-11 2025-03-30 0000802481 us-gaap:SettledLitigationMember ppc:HoganV.PilgrimsPrideCorporationEtAl.Member us-gaap:SubsequentEventMember 2025-02-05 2025-04-30 0000802481 us-gaap:PendingLitigationMember ppc:MexicanTaxAdministrationServiceAcquisitionOfTysonDeMexicoMember us-gaap:SubsequentEventMember 2025-04-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM | 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 30, 2025
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______
Commission File number 1-9273
PILGRIM’S PRIDE CORPORATION
(Exact name of registrant as specified in its charter)

Delaware |  | 75-1285071
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
1770 Promontory Circle |  | 80634-9038
Greeley | CO |  |
(Address of principal executive offices) |  | (Zip code)

Registrant’s telephone number, including area code: (970) 506-8000
Former name, former address and former fiscal year, if changed since last report: Not Applicable
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading symbol(s) |  | Name of each exchange on which registered
Common Stock, Par Value $0.01 |  | PPC |  | The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | ý |  | Accelerated Filer |  | ☐
Non-accelerated Filer | ☐ |  | Smaller reporting company |  | ☐
|  |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
Number of shares outstanding of the issuer’s common stock, $0.01 par value per share, as of April 30, 2025, was 237,123,061.

INDEX
PILGRIM’S PRIDE CORPORATION

PART I. FINANCIAL INFORMATION |
Item 1. | Condensed Consolidated Financial Statements | 2
| Condensed Consolidated Balance Sheets March 30, 2025 and December 29, 2024 | 2
| Condensed Consolidated Statements of Income Three Months Ended March 30, 2025 and March 31, 2024 | 3
| Condensed Consolidated Statements of Comprehensive Income Three Months Ended March 30, 2025 and March 31, 2024 | 4
| Condensed Consolidated Statements of Stockholders’ Equity Three Months Ended March 30, 2025 and March 31, 2024 | 5
| Condensed Consolidated Statements of Cash Flows Three Months Ended March 30, 2025 and March 31, 2024 | 6
| Notes to Condensed Consolidated Financial Statements | 7
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 32
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 40
Item 4. | Controls and Procedures | 43
PART II. OTHER INFORMATION | 44
Item 1. | Legal Proceedings | 44
Item 1A. | Risk Factors | 44
Item 5. | Other Information | 44
Item 6. | Exhibits | 44
SIGNATURES | 45

1

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

PILGRIM’S PRIDE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
|  | (Unaudited) |  |
|  | March 30, 2025 |  | December 29, 2024
|  | (In thousands)
Cash and cash equivalents |  | $ | 2,066,782 |  |  | $ | 2,040,834 |
Restricted cash and restricted cash equivalents |  | 10,685 |  |  | 2,324 |
Investment in available-for-sale securities |  | — |  |  | 10,220 |
Trade accounts and other receivables, less allowance for credit losses |  | 1,105,991 |  |  | 1,004,334 |
Accounts receivable from related parties |  | 10,612 |  |  | 2,608 |
Inventories |  | 1,856,305 |  |  | 1,783,488 |
Income taxes receivable |  | 55,597 |  |  | 72,414 |
Assets held for sale |  | 3,151 |  |  | 3,062 |
Prepaid expenses and other current assets |  | 257,915 |  |  | 200,879 |
Total current assets |  | 5,367,038 |  |  | 5,120,163 |
Deferred tax assets |  | 28,519 |  |  | 29,483 |
Other long-lived assets |  | 66,745 |  |  | 62,019 |
Operating lease assets, net |  | 248,178 |  |  | 255,713 |
Intangible assets, net |  | 820,275 |  |  | 806,234 |
Goodwill |  | 1,271,690 |  |  | 1,239,073 |
Property, plant and equipment, net |  | 3,161,314 |  |  | 3,137,891 |
Total assets |  | $ | 10,963,759 |  |  | $ | 10,650,576 |
Accounts payable |  | $ | 1,410,879 |  |  | $ | 1,411,519 |
Accounts payable to related parties |  | 27,280 |  |  | 15,257 |
Revenue contract liabilities |  | 42,412 |  |  | 48,898 |
Dividends payable |  | 1,495,382 |  |  | — |
Accrued expenses and other current liabilities |  | 919,606 |  |  | 1,015,504 |
Income taxes payable |  | 93,328 |  |  | 60,097 |
Current maturities of long-term debt |  | 862 |  |  | 858 |
Total current liabilities |  | 3,989,749 |  |  | 2,552,133 |
Noncurrent operating lease liabilities, less current maturities |  | 189,258 |  |  | 195,944 |
Long-term debt, less current maturities |  | 3,199,746 |  |  | 3,206,113 |
Deferred tax liabilities |  | 418,704 |  |  | 422,952 |
Other long-term liabilities |  | 18,855 |  |  | 20,038 |
Total liabilities |  | 7,816,312 |  |  | 6,397,180 |
Common stock |  | 2,625 |  |  | 2,623 |
Treasury stock |  | (544,687) |  |  | (544,687) |
Additional paid-in capital |  | 2,001,280 |  |  | 1,994,259 |
Retained earnings |  | 1,958,162 |  |  | 3,157,511 |
Accumulated other comprehensive loss |  | (284,233) |  |  | (370,300) |
Total Pilgrim’s Pride Corporation stockholders’ equity |  | 3,133,147 |  |  | 4,239,406 |
Noncontrolling interest |  | 14,300 |  |  | 13,990 |
Total stockholders’ equity |  | 3,147,447 |  |  | 4,253,396 |
Total liabilities and stockholders’ equity |  | $ | 10,963,759 |  |  | $ | 10,650,576 |

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
2

PILGRIM’S PRIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|  |  |  | Three Months Ended
|  |  |  |  |  | March 30, 2025 |  | March 31, 2024
|  |  |  |  | (In thousands, except per share data)
Net sales |  |  |  |  |  | $ | 4,463,009 |  |  | $ | 4,361,934 |
Cost of sales |  |  |  |  |  | 3,908,136 |  |  | 3,978,025 |
Gross profit |  |  |  |  |  | 554,873 |  |  | 383,909 |
Selling, general and administrative expense |  |  |  |  |  | 133,779 |  |  | 119,076 |
Restructuring activities |  |  |  |  |  | 16,612 |  |  | 14,559 |
Operating income |  |  |  |  |  | 404,482 |  |  | 250,274 |
Interest expense, net of capitalized interest |  |  |  |  |  | 41,738 |  |  | 41,243 |
Interest income |  |  |  |  |  | (24,953) |  |  | (10,346) |
Foreign currency transaction gains |  |  |  |  |  | (2,053) |  |  | (4,337) |
Miscellaneous, net |  |  |  |  |  | (692) |  |  | (3,286) |
Income before income taxes |  |  |  |  |  | 390,442 |  |  | 227,000 |
Income tax expense |  |  |  |  |  | 94,099 |  |  | 52,062 |
Net income |  |  |  |  |  | 296,343 |  |  | 174,938 |
Less: Net income attributable to noncontrolling interests |  |  |  |  |  | 310 |  |  | 517 |
Net income attributable to Pilgrim’s Pride Corporation |  |  |  |  |  | $ | 296,033 |  |  | $ | 174,421 |
Weighted average shares of Pilgrim’s Pride Corporation common stock outstanding: |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | 237,235 |  |  | 236,844 |
Effect of dilutive common stock equivalents |  |  |  |  |  | 1,045 |  |  | 647 |
Diluted |  |  |  |  |  | 238,280 |  |  | 237,491 |
Net income attributable to Pilgrim’s Pride Corporation per share of common stock outstanding: |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | $ | 1.25 |  |  | $ | 0.74 |
Diluted |  |  |  |  |  | $ | 1.24 |  |  | $ | 0.73 |

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
3

PILGRIM’S PRIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
|  |  | Three Months Ended
|  |  |  |  | March 30, 2025 |  | March 31, 2024
|  |  |  |  | (In thousands)
Net income |  |  |  |  | $ | 296,343 |  |  | $ | 174,938 |
Other comprehensive income (loss): |  |  |  |  |  |  |
Foreign currency translation adjustment: |  |  |  |  |  |  |
Gains (losses) arising during the period |  |  |  |  | 84,972 |  |  | (32,490) |
Derivative financial instruments designated as cash flow hedges: |  |  |  |  |  |  |
Gains arising during the period |  |  |  |  | 1,660 |  |  | 465 |
Reclassification to net earnings for gains realized |  |  |  |  | (10) |  |  | (1,041) |
Available-for-sale securities: |  |  |  |  |  |  |
Losses arising during the period |  |  |  |  | (79) |  |  | — |
Income tax effect |  |  |  |  | 19 |  |  | — |
Reclassification to net earnings for losses (gains) realized |  |  |  |  | 54 |  |  | (8) |
Income tax effect |  |  |  |  | (13) |  |  | 2 |
Defined benefit plans: |  |  |  |  |  |  |
Gains (losses) arising during the period |  |  |  |  | (591) |  |  | 4,139 |
Income tax effect |  |  |  |  | 115 |  |  | (1,054) |
Reclassification to net earnings for losses (gains) realized |  |  |  |  | (80) |  |  | 140 |
Income tax effect |  |  |  |  | 20 |  |  | (34) |
Total other comprehensive income (loss), net of tax |  |  |  |  | 86,067 |  |  | (29,881) |
Comprehensive income |  |  |  |  | 382,410 |  |  | 145,057 |
Less: Comprehensive income attributable to noncontrolling interests |  |  |  |  | 310 |  |  | 517 |
Comprehensive income attributable to Pilgrim’s Pride Corporation |  |  |  |  | $ | 382,100 |  |  | $ | 144,540 |

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
4

PILGRIM’S PRIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
Three Months Ended March 30, 2025 |  | Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
|  | Shares |  | Amount |  | Shares |  | Amount |
|  | (In thousands)
Balance at December 29, 2024 |  | 262,263 |  |  | $ | 2,623 |  |  | (25,142) |  |  | $ | (544,687) |  |  | $ | 1,994,259 |  |  | $ | 3,157,511 |  |  | $ | (370,300) |  |  | $ | 13,990 |  |  | $ | 4,253,396 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 296,033 |  |  | — |  |  | 310 |  |  | 296,343 |
Other comprehensive income, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 86,067 |  |  | — |  |  | 86,067 |
Stock-based compensation plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued under compensation plans |  | 258 |  |  | 2 |  |  | — |  |  | — |  |  | (2) |  |  | — |  |  | — |  |  | — |  |  | — |
Requisite service period recognition |  | — |  |  | — |  |  | — |  |  | — |  |  | 7,023 |  |  | — |  |  | — |  |  | — |  |  | 7,023 |
Special cash dividend |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,495,382) |  |  | — |  |  | — |  |  | (1,495,382) |
Balance at March 30, 2025 |  | 262,521 |  |  | $ | 2,625 |  |  | (25,142) |  |  | $ | (544,687) |  |  | $ | 2,001,280 |  |  | $ | 1,958,162 |  |  | $ | (284,233) |  |  | $ | 14,300 |  |  | $ | 3,147,447 |

Three Months Ended March 31, 2024 |  | Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
|  | Shares |  | Amount |  | Shares |  | Amount |
|  | (In thousands)
Balance at December 31, 2023 |  | 261,931 |  |  | $ | 2,620 |  |  | (25,142) |  |  | $ | (544,687) |  |  | $ | 1,978,849 |  |  | $ | 2,071,073 |  |  | $ | (176,483) |  |  | $ | 13,205 |  |  | $ | 3,344,577 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 174,421 |  |  | — |  |  | 517 |  |  | 174,938 |
Other comprehensive income, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (29,881) |  |  | — |  |  | (29,881) |
Stock-based compensation plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued under compensation plans |  | 153 |  |  | 1 |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |
Requisite service period recognition |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,744 |  |  | — |  |  | — |  |  | — |  |  | 4,744 |
Balance at March 31, 2024 |  | 262,084 |  |  | $ | 2,621 |  |  | (25,142) |  |  | $ | (544,687) |  |  | $ | 1,983,592 |  |  | $ | 2,245,494 |  |  | $ | (206,364) |  |  | $ | 13,722 |  |  | $ | 3,494,378 |

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
5

PILGRIM’S PRIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|  | Three Months Ended
|  | March 30, 2025 |  | March 31, 2024
|  | (In thousands)
Cash flows from operating activities: |  |  |  |
Net income |  | $ | 296,343 |  |  | $ | 174,938 |
Adjustments to reconcile net income to cash provided by operating activities: |  |  |  |
Depreciation and amortization |  | 104,518 |  |  | 103,350 |
Deferred income tax expense (benefit) |  | (10,958) |  |  | 15,519 |
Stock-based compensation |  | 7,023 |  |  | 4,744 |
Loan cost amortization |  | 1,239 |  |  | 1,311 |
Loss on property disposals |  | 900 |  |  | 1,842 |
Accretion of discount related to Senior Notes |  | 608 |  |  | 649 |
Asset impairment |  | 589 |  |  | — |
Gain on early extinguishment of debt recognized as a component of interest expense |  | (107) |  |  | — |
Gain on equity-method investments |  | (1) |  |  | (2) |
Changes in operating assets and liabilities: |  |  |  |
Trade accounts and other receivables |  | (91,504) |  |  | 72,350 |
Inventories |  | (64,233) |  |  | 114,471 |
Prepaid expenses and other current assets |  | (44,021) |  |  | (27,628) |
Accounts payable, accrued expenses and other current liabilities |  | (118,667) |  |  | (212,807) |
Income taxes |  | 51,887 |  |  | 35,797 |
Long-term pension and other postretirement obligations |  | (1,414) |  |  | (1,315) |
Other operating assets and liabilities |  | (5,311) |  |  | (12,192) |
Cash provided by operating activities |  | 126,891 |  |  | 271,027 |
Cash flows from investing activities: |  |  |  |
Acquisitions of property, plant and equipment |  | (98,274) |  |  | (108,429) |
Proceeds from property disposals |  | 1,185 |  |  | 2,217 |
Cash used in investing activities |  | (97,089) |  |  | (106,212) |
Cash flows from financing activities: |  |  |  |
Payments on revolving line of credit, long-term borrowings and finance lease obligations |  | (3,553) |  |  | (153) |
Proceeds from contribution of capital under Tax Sharing Agreement between JBS USA Holdings and Pilgrim’s Pride Corporation |  | — |  |  | 1,425 |
Payments of capitalized loan costs |  | — |  |  | (16) |
Cash provided by (used in) financing activities |  | (3,553) |  |  | 1,256 |
Effect of exchange rate changes on cash and cash equivalents |  | 8,060 |  |  | (2,411) |
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents |  | 34,309 |  |  | 163,660 |
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period |  | 2,043,158 |  |  | 731,223 |
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |  | $ | 2,077,467 |  |  | $ | 894,883 |

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business
Pilgrim’s Pride Corporation (referred to herein as “Pilgrim’s,” “PPC,” “the Company,” “we,” “us,” “our,” or similar terms) is one of the largest food companies in the world, with operations in the United States (“U.S.”), the United Kingdom (“U.K.”), Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. Pilgrim’s is primarily a chicken producer, with pork and lamb operations in the U.K. Pilgrim’s products are sold to foodservice, retail and frozen entrée customers. The Company’s primary distribution is through retailers, foodservice distributors and restaurants throughout the countries listed above. Additionally, the Company exports chicken and pork products (from its U.K. operations) to over 110 countries. Our fresh products consist of refrigerated whole or cut-up chicken, selected chicken parts that are either marinated or non-marinated, primary pork cuts, added value pork, pork ribs, and lamb products. The Company’s prepared products include fully cooked, ready-to-cook and individually frozen chicken parts, strips, nuggets and patties, processed sausages, bacon, smoked meat, gammon joints, pre-packed meats, sandwich and deli counter meats and meatballs. The Company’s other products include plant-based protein offerings, ready-to-eat meals, multi-protein frozen foods, vegetarian foods and desserts. The Company also provides direct-to-consumer meals and hot food to-go solutions in the U.K. and the Republic of Ireland. We operate feed mills, hatcheries, processing plants and distribution centers in 14 U.S. states, the U.K., Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. As of March 30, 2025, Pilgrim’s had approximately 62,600 employees and had the capacity to process approximately 41.3 million birds per 5-day work week. Approximately 4,300 contract growers supply chicken for the Company’s operations. As of March 30, 2025, PPC had the capacity to process approximately 42,750 pigs per 5-day work week and 205 contract growers supply pigs for the Company’s U.K. operations. As of March 30, 2025, JBS S.A., through its indirect wholly-owned subsidiaries (collectively, “JBS”), beneficially owned 82.3% of the Company’s outstanding common stock.
Condensed Consolidated Financial Statements
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal and recurring adjustments unless otherwise disclosed) considered necessary for a fair presentation have been included. Operating results for the three months ended March 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 28, 2025. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 29, 2024.
The Company operates on the basis of a 52/53 week fiscal year ending on the Sunday falling on or before December 31. Any reference we make to a particular year (for example, 2025) in the notes to these Condensed Consolidated Financial Statements applies to our fiscal year and not the calendar year. The three months ended March 30, 2025 represents the period from December 30, 2024 through March 30, 2025. The three months ended March 31, 2024 represents the period from January 1, 2024 through March 31, 2024.
The Condensed Consolidated Financial Statements include the accounts of the Company and its majority-owned subsidiaries. We eliminate all significant affiliate accounts and transactions upon consolidation.
The Condensed Consolidated Financial Statements have been prepared in conformity with U.S. GAAP using management’s best estimates and judgments. These estimates and judgments affect the reported amounts of assets and liabilities and disclosure of the contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ materially from these estimates and judgments. Significant estimates made by the Company include the allowance for credit losses, reserves related to inventory obsolescence or valuation, useful lives of long-lived assets, goodwill, identifiable intangible assets, valuation of deferred tax assets, insurance accruals, valuation of pension and other postretirement benefits obligations, income tax accruals, certain derivative positions, and valuations of acquired businesses.
The functional currency of the Company’s U.S. operations and certain holding-company subsidiaries in Luxembourg, the U.K., Malta and the Republic of Ireland is the U.S. dollar. The functional currency of its U.K. operations is the British pound. The functional currency of the Company’s operations in France, the Netherlands and the Republic of Ireland is the euro. The Company has determined that there was a significant change in economic factors that necessitated a reassessment of the appropriate functional currency of the Mexico reportable segment. The primary economic factors driving the change include 1)
7

Table of Contents
the recent sustained, historical strengthening of the Mexican peso against the U.S. dollar and against other global currencies without a correlated impact on the average product sales prices of our Mexico operations and 2) a shift in the proportional volume of spend we have that is denominated in Mexican peso in relation to spend that is denominated in U.S. dollar. As a result of this reassessment, on April 1, 2024, the Company changed the functional currency of its Mexico operations from U.S. dollar to the Mexican peso. The change in the functional currency was accounted for on April 1, 2024, and did not have a material impact on our consolidated financial statements. For foreign currency-denominated entities, including the Company’s Mexico operations after April 1, 2024, translation from local currencies into U.S. dollars is performed for assets and liabilities using the exchange rates in effect as of the balance sheet date. Income and expense accounts are remeasured using average exchange rates for the period. Adjustments resulting from translation of these financial records are reflected as a separate component of Accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets. For the Company’s Mexico operations prior to April 1, 2024, remeasurement from the Mexican peso to U.S. dollars was performed for monetary assets and liabilities using the exchange rate in effect as of the balance sheet date. Remeasurement was performed for non-monetary assets using the historical exchange rate in effect on the date of each asset’s acquisition. Income and expense accounts were remeasured using average exchange rates for the period. Net adjustments that resulted from remeasurement of the financial records, as well as foreign currency transaction gains and losses, are reflected in Foreign currency transaction losses (gains) in the Condensed Consolidated Statements of Income.
Restricted Cash and Restricted Cash Equivalents
The Company is required to maintain cash balances with brokers as collateral for exchange-traded futures contracts. These balances are classified as restricted cash as they are not available for use by the Company to fund daily operations. The balance of restricted cash and restricted cash equivalents may also include investments in U.S. Treasury Bills that qualify as restricted cash equivalents, as required by the brokers, to offset the obligation to return cash collateral.
The following table reconciles cash, cash equivalents, restricted cash and restricted cash equivalents as reported in the Condensed Consolidated Balance Sheets to the total of the same amounts shown in the Condensed Consolidated Statements of Cash Flows:

|  | March 30, 2025 |  | December 29, 2024
|  | (In thousands)
Cash and cash equivalents |  | $ | 2,066,782 |  |  | $ | 2,040,834 |
Restricted cash and restricted cash equivalents |  | 10,685 |  |  | 2,324 |
Total cash, cash equivalents, restricted cash and restricted cash equivalents shown in the Condensed Consolidated Statements of Cash Flows |  | $ | 2,077,467 |  |  | $ | 2,043,158 |

Recent Accounting Pronouncements Not Yet Adopted as of March 30, 2025
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures for income taxes to enhance transparency and usefulness of income tax disclosures. The guidance requires additional disclosures for the tabular rate reconciliation, income taxes paid, and the disaggregation of domestic, federal and state, and foreign components within income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) from continuing operations. The provisions of the new guidance are effective for annual periods beginning after December 15, 2024. The Company plans to adopt this guidance as it becomes effective and is assessing the impacts on our Consolidated Financial Statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40), which requires additional disclosures for certain costs and expenses to help investors better understand major components of an entity’s income statement. The guidance requires additional disclosures for costs and expenses such as purchases of inventory, employee compensation, depreciation, and intangible asset amortization. The provisions of the new guidance will be effective for annual reporting years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company plans to adopt this guidance as it becomes effective and is assessing the impacts on our Consolidated Financial Statements.
2. REVENUE RECOGNITION
The vast majority of the Company’s revenue is derived from contracts which are based upon a customer ordering its products. While there may be master agreements, the contract is only established when the customer’s order is accepted by the Company. The Company accounts for a contract, which may be verbal or written, when it is approved and committed by both parties, the rights of the parties are identified along with payment terms, the contract has commercial substance and collectability is probable.
8

Table of Contents
The Company evaluates the transaction for distinct performance obligations, which are the sale of its products to customers. Since its products are commodity market-priced, the sales price is representative of the observable, standalone selling price. Each performance obligation is recognized based upon a pattern of recognition that reflects the transfer of control to the customer at a point in time, which is upon destination (customer location or port of destination), and depicts the transfer of control and recognition of revenue. There are instances of customer pick-up at the Company’s facilities, in which case control transfers to the customer at that point and the Company recognizes revenue. The Company’s performance obligations are typically fulfilled within days to weeks of the acceptance of the order.
The Company makes judgments regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from revenue and cash flows with customers. Determination of a contract requires evaluation and judgment along with the estimation of the total contract value and if any of the contract value is constrained. Due to the nature of our business, there is minimal variable consideration, as the contract is established at the acceptance of the order from the customer. When applicable, variable consideration is estimated at contract inception and updated on a regular basis until the contract is completed. Allocating the transaction price to a specific performance obligation based upon the relative standalone selling prices includes estimating the standalone selling prices including discounts and variable consideration.
Disaggregated Revenue
Revenue has been disaggregated into the categories below to show how economic factors affect the nature, amount, timing and uncertainty of revenue and cash flows:

| Three Months Ended March 30, 2025
| (In thousands)
| Fresh |  | Prepared |  | Export |  | Other (a) |  | Total
U.S. | $ | 2,214,885 |  |  | $ | 323,909 |  |  | $ | 109,165 |  |  | $ | 95,230 |  |  | $ | 2,743,189 |
Europe | 322,054 |  |  | 758,678 |  |  | 123,861 |  |  | 26,936 |  |  | 1,231,529 |
Mexico | 411,895 |  |  | 50,415 |  |  | — |  |  | 25,981 |  |  | 488,291 |
Total net sales | $ | 2,948,834 |  |  | $ | 1,133,002 |  |  | $ | 233,026 |  |  | $ | 148,147 |  |  | $ | 4,463,009 |

| Three Months Ended March 31, 2024
| (In thousands)
| Fresh |  | Prepared |  | Export |  | Other (a) |  | Total
U.S. | $ | 2,113,623 |  |  | $ | 268,990 |  |  | $ | 108,798 |  |  | $ | 87,921 |  |  | $ | 2,579,332 |
Europe | 271,148 |  |  | 844,996 |  |  | 118,451 |  |  | 33,308 |  |  | 1,267,903 |
Mexico | 430,152 |  |  | 55,520 |  |  | — |  |  | 29,027 |  |  | 514,699 |
Total net sales | $ | 2,814,923 |  |  | $ | 1,169,506 |  |  | $ | 227,249 |  |  | $ | 150,256 |  |  | $ | 4,361,934 |

(a) Included in Other sales shown above are sales of commodity grains and protein byproducts
Additional disaggregation of revenue by sales channel is provided below:

| Three Months Ended March 30, 2025
| (In thousands)
| Retail |  | Foodservice |  | Export |  | Other |  | Total
U.S. | $ | 1,543,660 |  |  | $ | 988,477 |  |  | $ | 109,165 |  |  | $ | 101,887 |  |  | $ | 2,743,189 |
Europe | 771,854 |  |  | 226,544 |  |  | 123,861 |  |  | 109,270 |  |  | 1,231,529 |
Mexico(a) | 124,046 |  |  | 226,811 |  |  | — |  |  | 137,434 |  |  | 488,291 |
Total net sales | $ | 2,439,560 |  |  | $ | 1,441,832 |  |  | $ | 233,026 |  |  | $ | 348,591 |  |  | $ | 4,463,009 |

9

Table of Contents

| Three Months Ended March 31, 2024
| (In thousands)
| Retail |  | Foodservice |  | Export |  | Other |  | Total
U.S. | $ | 1,426,237 |  |  | $ | 935,249 |  |  | $ | 108,798 |  |  | $ | 109,048 |  |  | $ | 2,579,332 |
Europe | 812,257 |  |  | 201,827 |  |  | 118,451 |  |  | 135,368 |  |  | 1,267,903 |
Mexico(a) | 135,259 |  |  | 239,723 |  |  | — |  |  | 139,717 |  |  | 514,699 |
Total net sales | $ | 2,373,753 |  |  | $ | 1,376,799 |  |  | $ | 227,249 |  |  | $ | 384,133 |  |  | $ | 4,361,934 |

(a)Included in Mexico foodservice channel are sales to wholesale public meat markets that typically sell product on to foodservice customers. Included in Mexico other channel are sales to live chicken markets.
Contract Costs
The Company can incur incremental costs to obtain or fulfill a contract such as broker expenses that are not expected to be recovered. The amortization period for such expenses is less than one year; therefore, the costs are expensed as incurred.
Taxes
The Company excludes all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer (for example, sales, use, value added and some excise taxes) from the transaction price.
Contract Balances
The Company receives payment from customers based on terms established with the customer. Payments are typically due within 14 to 30 days of delivery. Revenue contract liabilities relate to payments received in advance of satisfying the performance under the customer contract. The revenue contract liabilities relate to customer prepayments and the advanced consideration, such as cash, received from governmental agency contracts for which performance obligations to the end customer have not been satisfied.
Changes in the revenue contract liabilities balance are as follows (in thousands):

Balance as of December 29, 2024 | $ | 48,898 |
Revenue recognized | (40,671) |
Cash received, excluding amounts recognized as revenue during the period | 34,193 |
Effect of exchange rates | (8) |
Balance as of March 30, 2025 | $ | 42,412 |

Accounts Receivable
The Company records accounts receivable when revenue is recognized. We record an allowance for credit losses, reducing our receivables balance to an amount we estimate is collectible from our customers. Estimates used in determining the allowance for credit losses are based on historical collection experience, current trends, aging of accounts receivable and periodic credit evaluations of our customers’ financial condition. We write off accounts receivable when it becomes apparent, based upon age or customer circumstances, that such amounts will not be collected. Generally, the Company does not require collateral for its accounts receivable.
3. DERIVATIVE FINANCIAL INSTRUMENTS
The Company utilizes various raw materials in its operations, including corn, soybean meal, soybean oil, wheat, natural gas, electricity and diesel fuel, which are all considered commodities. The Company considers these raw materials generally available from a number of different sources and believes it can obtain them to meet its requirements. These commodities are subject to price fluctuations and related price risk due to factors beyond our control, such as economic and political conditions, supply and demand, weather, governmental regulation and other circumstances. Generally, the Company purchases derivative financial instruments, specifically exchange-traded futures and options, in an attempt to mitigate price risk related to its anticipated consumption of commodity inputs for approximately the next twelve months. The Company may purchase longer-term derivative financial instruments on particular commodities if deemed appropriate.
The Company has operations in Mexico, the U.K., France, the Netherlands and the Republic of Ireland. Therefore, it has exposure to translational foreign exchange risk when the financial results of those operations are remeasured in U.S. dollars. The Company has purchased foreign currency forward contracts to manage a portion of this foreign exchange risk.
10

Table of Contents
The fair value of derivative assets is included in the line item Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets while the fair value of derivative liabilities is included in the line item Accrued expenses and other current liabilities on the same statements. The Company’s counterparties require that it post collateral for changes in the net fair value of the derivative contracts. This cash collateral is reported in the line item Restricted cash and restricted cash equivalents on the Condensed Consolidated Balance Sheets.
Undesignated contracts may include contracts not designated as hedges or contracts that do not qualify for hedge accounting. The fair value of each of these derivatives is recognized in the Condensed Consolidated Balance Sheets within Prepaid expenses and other current assets or Accrued expenses and other current liabilities. Changes in fair value of each derivative are recognized immediately in the Condensed Consolidated Statements of Income within Net sales, Cost of sales, or Foreign currency transaction losses (gains) depending on the risk the derivative is intended to mitigate. While management believes these instruments help mitigate various market risks, they are not designated and accounted for as hedges as a result of the extensive record keeping requirements.
The Company does not apply hedge accounting treatment to certain derivative financial instruments that it has purchased to mitigate commodity purchase exposures in the U.S. and Mexico or foreign currency transaction exposures on our Mexico operations. Therefore, the Company recognized changes in the fair value of these derivative financial instruments immediately in earnings. Gains or losses related to the commodity derivative financial instruments are included in the line item Cost of sales in the Condensed Consolidated Statements of Income. Realized gains and losses related to cash flows are disclosed in the Condensed Consolidated Statements of Cash Flows in Cash provided by operating activities. Unrealized gains and losses related to cash flows are disclosed in the Condensed Consolidated Statements of Cash Flows in the line item Other operating assets and liabilities. Gains or losses related to the foreign currency derivative financial instruments are included in the line item Foreign currency transaction losses (gains) in the Condensed Consolidated Statements of Income.
The Company does apply hedge accounting treatment to certain derivative financial instruments related to its Europe reportable segment that it has purchased to mitigate foreign currency transaction exposures. Before the settlement date of the financial derivative instruments, the Company recognizes changes in the fair value of the cash flow hedge into accumulated other comprehensive income (“AOCI”). When the derivative financial instruments are settled, the amount in AOCI is then reclassified to earnings. Gains or losses related to these derivative financial instruments are included in the line item Net sales and Cost of sales in the Condensed Consolidated Statements of Income.
We have generally applied the normal purchase and normal sale scope exception (“NPNS”) to our forward physical grain purchase contracts delivered by truck and to our forward physical natural gas and solar-generated power purchase contracts. NPNS contracts are accounted for using the accrual method of accounting; therefore, amounts payable under these contracts are recorded when we take delivery of the contracted product and no amounts were recorded for the fair value of these contracts in the condensed consolidated financial statements at March 30, 2025 and December 29, 2024.
Information regarding the Company’s outstanding derivative instruments and cash collateral posted with brokers is included in the following table:

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Fair values: |  |  |
Commodity derivative assets | $ | 5,552 |  |  | $ | 6,598 |
Commodity derivative liabilities | (11,912) |  |  | (2,494) |
Foreign currency derivative assets | 1,246 |  |  | 755 |
Foreign currency derivative liabilities | (237) |  |  | (1,397) |
Sales contract derivative assets | 1,652 |  |  | — |
Sales contract derivative liabilities | — |  |  | (778) |
Cash collateral posted with brokers(a) | 10,685 |  |  | 2,324 |
Derivatives coverage(b): |  |  |
Corn | 26.4 | % |  | 11.5 | %
Soybean meal | 13.1 | % |  | 9.3 | %
Period through which stated percent of needs are covered: |  |  |
Corn | December 2025 |  | December 2025
Soybean meal | March 2026 |  | March 2026

(a)Collateral posted with brokers consists primarily of cash, short-term treasury bills or other cash equivalents.
(b)Derivatives coverage is the percent of anticipated commodity needs covered by outstanding derivative instruments through a specified date.
11

Table of Contents
The following table presents the gains and losses of each derivative instrument held by the Company not designated or qualifying as hedging instruments:

| Three Months Ended |  |  |
Type of Contract (a) | March 30, 2025 |  | March 31, 2024 |  |  |  |  | Affected Line Item in the Condensed Consolidated Statements of Income
| (In thousands) |  |  |  |
Commodity derivatives | (7,185) |  |  | (10,048) |  |  |  |  |  | Cost of sales
Sales contract derivatives | 2,430 |  |  | 2,095 |  |  |  |  |  | Net sales
Total | $ | (4,755) |  |  | $ | (7,953) |  |  |  |  |  |

(a)Amounts represent income (expenses) related to results of operations.
The following tables present the components of the gain or loss on derivatives that qualify as cash flow hedges:

| Gains (Losses) Recognized in Other Comprehensive Income (Loss) |  |  |  |
| Three Months Ended |  |
| March 30, 2025 |  | March 31, 2024 |  |  |  |
| (In thousands) |  |  |  |
Foreign currency derivatives | $ | 1,673 |  |  | $ | 455 |  |  |  |  |

| Gains (Losses) Reclassified from AOCI into Income
| Three Months Ended March 30, 2025 |  | Three Months Ended March 31, 2024
| Net sales(a) |  | Cost of sales(b) |  | Net sales(a) |  | Cost of sales(b)
| (In thousands)
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Income in which the effects of cash flow hedges are recorded | $ | 4,463,009 |  |  | $ | 3,908,136 |  |  | $ | 4,361,934 |  |  | $ | 3,978,025 |
Impact from cash flow hedging instruments: |  |  |  |  |  |  |
Foreign currency derivatives | (3) |  |  | (13) |  |  | 1,041 |  |  | — |

(a) Amounts represent income (expenses) related to net sales.
(b) Amounts represent expenses (income) related to cost of sales.
At March 30, 2025, there was a $0.4 million pre-tax deferred net loss on foreign currency derivatives recorded in AOCI that is expected to be reclassified to the Condensed Consolidated Statements of Income during the next twelve months. This expectation is based on the anticipated settlements on the hedged investments in foreign currencies that will occur over the next twelve months, at which time the Company will recognize the deferred loss to earnings.
12

Table of Contents
4. TRADE ACCOUNTS AND OTHER RECEIVABLES
Trade accounts and other receivables, less allowance for credit losses, consisted of the following:

|  | March 30, 2025 |  | December 29, 2024
|  | (In thousands)
Trade accounts receivable |  | $ | 1,081,950 |  |  | $ | 973,820 |
Notes receivable from third parties |  | 8,946 |  |  | 8,970 |
Other receivables |  | 23,543 |  |  | 30,018 |
Receivables, gross |  | 1,114,439 |  |  | 1,012,808 |
Allowance for credit losses |  | (8,448) |  |  | (8,474) |
Receivables, net |  | $ | 1,105,991 |  |  | $ | 1,004,334 |
Accounts receivable from related parties(a) |  | $ | 10,612 |  |  | $ | 2,608 |

(a) Additional information regarding accounts receivable from related parties is included in “Note 17. Related Party Transactions.”
Activity in the allowance for credit losses was as follows:

|  | Three Months Ended
|  | March 30, 2025
|  | (In thousands)
Balance, beginning of period |  | $ | (8,474) |
Provision charged to operating results |  | (180) |
Account write-offs and recoveries |  | 242 |
Effect of exchange rate |  | (36) |
Balance, end of period |  | $ | (8,448) |

In June 2023, the Company and JBS USA Food Company (“JBS USA”) jointly entered into a receivables purchase agreement with a bank for an uncommitted facility with a maximum capacity of $415.0 million and no recourse to the Company or JBS USA. Under the facility, the Company may sell eligible trade receivables in exchange for cash. Transfers under the agreement are recorded as a sale under ASC 860, Broad Transactions – Transfers and Servicing. At the transfer date, the Company receives cash equal to the face value of the receivables sold less a fee based on the current Secured Overnight Financing Rate (“SOFR”) plus an applicable margin applied over the customer payment term. The fees are immaterial.
5. INVENTORIES
Inventories consisted of the following:

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Raw materials and work-in-process | $ | 1,128,190 |  |  | $ | 1,069,170 |
Finished products | 538,784 |  |  | 527,364 |
Operating supplies | 75,339 |  |  | 77,146 |
Maintenance materials and parts | 113,992 |  |  | 109,808 |
Total inventories | $ | 1,856,305 |  |  | $ | 1,783,488 |

6. INVESTMENTS IN SECURITIES
The Company recognizes investments in available-for-sale securities as cash equivalents, current investments or long-term investments depending upon each security’s length to maturity. The following table summarizes our investments in available-for-sale securities:
13

Table of Contents

|  | March 30, 2025 |  | December 29, 2024
|  | Amortized Cost |  | Fair Value |  | Amortized Cost |  | Fair Value
|  | (In thousands)
Cash equivalents: |  |  |  |  |  |  |  |
Fixed income securities |  | $ | 1,812,032 |  |  | $ | 1,812,058 |  |  | $ | 1,702,493 |  |  | $ | 1,702,697 |
Short-term investments: |  |  |  |  |  |  |  |
Fixed income securities |  | — |  |  | — |  |  | 10,000 |  |  | 10,220 |

Interest income during the three months ended March 30, 2025 related to the Company’s available-for-sale securities totaled $23.6 million, the gains were immaterial. Gross realized gains during the three months ended March 31, 2024 were $8.0 million. Proceeds received from the sale or maturity of available-for-sale securities investments are historically disclosed in the Condensed Consolidated Statements of Cash Flows. Net unrealized holding gains and losses on the Company’s available-for-sale securities recognized during the three months ended March 30, 2025 and March 31, 2024 that have been included in AOCI and the net amount of gains and losses reclassified out of AOCI to earnings during the three months ended March 30, 2025 and March 31, 2024 are disclosed in “Note 13. Stockholders’ Equity.”
7. GOODWILL AND INTANGIBLE ASSETS
The activity in goodwill by segment for the three months ended March 30, 2025 was as follows:

|  | December 29, 2024 |  |  |  | Currency Translation |  | March 30, 2025
|  | (In thousands)
U.S. |  | $ | 41,936 |  |  |  |  | $ | — |  |  | $ | 41,936 |
Europe |  | 1,097,643 |  |  |  |  | 32,822 |  |  | 1,130,465 |
Mexico |  | 99,494 |  |  |  |  | (205) |  |  | 99,289 |
Total |  | $ | 1,239,073 |  |  |  |  | $ | 32,617 |  |  | $ | 1,271,690 |

Intangible assets consisted of the following:

|  | December 29, 2024 |  |  |  | Amortization |  | Currency Translation |  | March 30, 2025
|  | (In thousands)
Cost: |  |  |  |  |  |  |  |  |  |
Trade names not subject to amortization |  | $ | 569,357 |  |  |  |  | $ | — |  |  | $ | 16,610 |  |  | $ | 585,967 |
Trade names subject to amortization |  | 112,016 |  |  |  |  | — |  |  | 1,023 |  |  | 113,039 |
Customer relationships |  | 431,861 |  |  |  |  | — |  |  | 8,408 |  |  | 440,269 |
Accumulated amortization: |  |  |  |  |  |  |  |  |  |
Trade names |  | (61,527) |  |  |  |  | (965) |  |  | (203) |  |  | (62,695) |
Customer relationships |  | (245,473) |  |  |  |  | (7,025) |  |  | (3,807) |  |  | (256,305) |
Intangible assets, net |  | $ | 806,234 |  |  |  |  | $ | (7,990) |  |  | $ | 22,031 |  |  | $ | 820,275 |

Intangible assets are amortized over the estimated useful lives of the assets as follows:

Customer relationships | 3-18 years
Trade names subject to amortization | 15-20 years

At March 30, 2025, the Company assessed if events or changes in circumstances indicated that any asset group-level carrying amounts of its U.S. and Mexico intangible assets might not be recoverable. The Company will perform its annual tests of recoverability of all goodwill and trade names not subject to amortization in the fourth quarter of 2024, which if there were to be an impairment could be material.
14

Table of Contents
8. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment (“PP&E”), net consisted of the following:

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Land | $ | 214,469 |  |  | $ | 215,305 |
Buildings | 2,334,653 |  |  | 2,307,851 |
Machinery and equipment | 4,216,986 |  |  | 4,137,561 |
Autos and trucks | 134,506 |  |  | 130,013 |
Finance lease assets | 4,275 |  |  | 4,275 |
Construction-in-progress | 333,271 |  |  | 299,933 |
PP&E, gross | 7,238,160 |  |  | 7,094,938 |
Accumulated depreciation | (4,076,846) |  |  | (3,957,047) |
PP&E, net | $ | 3,161,314 |  |  | $ | 3,137,891 |

The Company recognized depreciation expense of $96.5 million and $95.2 million during the three months ended March 30, 2025 and March 31, 2024, respectively.
During the three months ended March 30, 2025, the Company incurred $98.8 million on capital projects and transferred $63.5 million of completed projects from construction-in-progress to depreciable assets. During the three months ended March 31, 2024, the Company spent $99.1 million on capital projects and transferred $133.7 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the periods ended March 30, 2025 and December 29, 2024 were $29.8 million and $29.2 million, respectively.
During the three months ended March 30, 2025, the Company sold certain PP&E for $1.2 million in cash and recognized a net loss of $0.9 million on these sales. During the three months ended March 31, 2024, the Company sold certain PP&E for $2.2 million in cash and recognized a net loss of $1.8 million on these sales.
The Company has closed or idled various other facilities in the U.S. and in the U.K. The Board of Directors has not determined if it would be in the best interest of the Company to divest any of these idled assets. Management is therefore not certain that it can or will divest any of these assets within one year, is not actively marketing these assets and, accordingly, has not classified them as assets held for sale. The Company continues to depreciate these assets. As of March 30, 2025, the carrying amounts of these idled assets totaled $40.8 million based on depreciable value of $168.8 million and accumulated depreciation of $128.0 million. Idled asset values include those assets that are no longer in use as a result of the recent restructuring activities of our Europe reportable segment. During the three months ended March 30, 2025, the Company recognized an additional impairment loss on PP&E of $0.6 million incurred as a result of those restructuring activities. Additional information regarding restructuring activities is included in “Note 16. Restructuring-Related Activities.”
As of March 30, 2025, the Company assessed if events or changes in circumstances indicated that the asset group-level carrying amounts of its PP&E held for use might not be recoverable. There were no indicators present that required the Company to test the recoverability of the asset group-level carrying amounts of its PP&E held for use at that date.
15

Table of Contents
9. CURRENT LIABILITIES
Current liabilities, other than income taxes and current maturities of long-term debt, consisted of the following components:

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Accounts payable: |  |  |
Trade accounts payable | $ | 1,290,513 |  |  | $ | 1,269,417 |
Book overdrafts | 91,527 |  |  | 113,364 |
Other payables | 28,839 |  |  | 28,738 |
Total accounts payable | 1,410,879 |  |  | 1,411,519 |
Accounts payable to related parties(a) | 27,280 |  |  | 15,257 |
Revenue contract liabilities(b) | 42,412 |  |  | 48,898 |
Dividends payable(c) | 1,495,382 |  |  | — |
Accrued expenses and other current liabilities: |  |  |
Compensation and benefits | 246,121 |  |  | 346,355 |
Litigation settlements(d) | 109,519 |  |  | 111,769 |
Accrued sales rebates | 107,977 |  |  | 116,439 |
Insurance and self-insured claims | 92,796 |  |  | 76,025 |
Current maturities of operating lease liabilities | 61,828 |  |  | 63,327 |
Interest and debt-related fees | 56,428 |  |  | 65,192 |
Taxes | 50,890 |  |  | 35,938 |
Derivative liabilities(e) | 12,149 |  |  | 4,669 |
Other accrued expenses | 181,898 |  |  | 195,790 |
Total accrued expenses and other current liabilities | 919,606 |  |  | 1,015,504 |
Total | $ | 3,895,559 |  |  | $ | 2,491,178 |

(a) Additional information regarding accounts payable to related parties is included in “Note 17. Related Party Transactions.”
(b) Additional information regarding revenue contract liabilities is included in “Note 2. Revenue Recognition.”
(c) Additional information regarding dividends payable is included in "Note 13. Stockholders' Equity."
(d) Additional information regarding litigation settlements is included in “Note 19. Commitments and Contingencies.”
(e) Additional information regarding derivative liabilities is included in “Note 3. Derivative Financial Instruments.”
10. SUPPLIER FINANCE PROGRAMS
The Company maintains supplier finance programs, under which we agree to pay for invoices that are confirmed as valid under the program from participating suppliers to a financing entity. Maturity dates are generally between 65-120 days and we pay either the supplier or the financing entity depending on the supplier’s election. We do not have an economic interest in a supplier's participation in the program or a direct financial relationship with the financial institution funding the program. As of March 30, 2025 and December 29, 2024, the outstanding balance of confirmed invoices was $202.8 million and $152.8 million respectively and are included in Accounts Payable in the Consolidated Balance Sheets.
16

Table of Contents
11. INCOME TAXES
The Company recorded income tax expense of $94.1 million, a 24.1% effective tax rate, for the three months ended March 30, 2025 compared to income tax expense of $52.1 million, a 22.9% effective tax rate, for the three months ended March 31, 2024. The increased income tax expense in 2025 resulted primarily from the increase of profit before income taxes.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carry back and carry forward periods), projected future taxable income and tax-planning strategies in making this assessment. As of March 30, 2025, the Company did not believe it had sufficient positive evidence to conclude that a portion of its foreign net deferred tax assets are more likely than not to be realized.
For the three months ended March 30, 2025 there are immaterial tax effects reflected in other comprehensive income. For the three months ended March 31, 2024, there is a tax effect of $(1.1) million reflected in other comprehensive income.
For the three months ended March 30, 2025 and March 31, 2024, there are immaterial tax effects reflected in income tax expense due to excess tax windfalls and shortfalls related to stock-based compensation.
The Company operates in the U.S. (including multiple state jurisdictions), Puerto Rico and several foreign locations including Mexico, the U.K., the Republic of Ireland, and continental Europe. With few exceptions, the Company is no longer subject to examinations by taxing authorities for years prior to 2020 in U.S. federal, state and local jurisdictions, for years prior to 2010 in Mexico, and for years prior to 2017 in the U.K.
On December 30, 2024, the Company entered into a tax sharing agreement (the “Tax Sharing Agreement”) with JBS USA governing the allocation, and certain payment and reimbursement obligations of U.S. income tax liabilities and assets among the Company and its relevant U.S. corporate subsidiaries, on the one hand, and JBS USA and its relevant U.S. subsidiaries, on the other hand. The Tax Sharing Agreement is effective for each tax year beginning on or after December 30, 2024 or such other date in which PPC becomes a member of the Parent Consolidated Group (as defined in the Tax Sharing Agreement).
Starting in 2024, Pillar II legislation has come into effect in various countries, impacting multinational companies operating in these jurisdictions. As of March 30, 2025 the Company continues to monitor Pillar II legislation and guidance and has yet to accrue any top-up taxes in the Condensed Consolidated Financial Statements.
12. DEBT
Long-term debt and other borrowing arrangements, including current notes payable to banks, consisted of the following components:

| Maturity |  | March 30, 2025 |  | December 29, 2024
|  |  | (In thousands)
Senior notes payable, net of discount, at 6.875% | 2034 |  | $ | 491,560 |  |  | $ | 491,329 |
Senior notes payable, net of discount, at 6.25% | 2033 |  | 972,976 |  |  | 974,381 |
Senior notes payable at 3.50% | 2032 |  | 900,000 |  |  | 900,000 |
Senior notes payable, net of discount, at 4.25% | 2031 |  | 848,568 |  |  | 850,342 |
U.S. Credit Facility (defined below) at SOFR plus 1.35% | 2028 |  | — |  |  | — |
Europe Credit Facility (defined below) with notes payable at SONIA plus 1.25% | 2027 |  | — |  |  | — |
Mexico Credit Facility (defined below) with notes payable at TIIE plus 1.35% | 2026 |  | — |  |  | — |
Live Oak CHP Project PACE Loan 5.15% | 2053 |  | 18,478 |  |  | 20,599 |
Finance lease obligations | Various |  | 1,663 |  |  | 1,792 |
Long-term debt |  |  | 3,233,245 |  |  | 3,238,443 |
Less: Current maturities of long-term debt |  |  | (862) |  |  | (858) |
Long-term debt, less current maturities |  |  | 3,232,383 |  |  | 3,237,585 |
Less: Capitalized financing costs |  |  | (32,637) |  |  | (31,472) |
Long-term debt, less current maturities, net of capitalized financing costs |  |  | $ | 3,199,746 |  |  | $ | 3,206,113 |

17

Table of Contents
Bond Repurchase Program
On May 1, 2024, the Board approved a bond repurchase program which permits the Company to repurchase up to an aggregate authorized amount of the Company’s outstanding senior notes. As of March 30, 2025, the authorization was for repurchases up to $200.0 million. The Board may determine to increase this authorization from time to time as it deems appropriate. Under the program, the Company has repurchased $2.0 million of outstanding principal of the Senior Notes due 2031 and $1.6 million of outstanding principal of the Senior Notes due 2033 in the three months ended March 30, 2025, resulting in immaterial gross realized gains recognized. The gross realized gains on early extinguishment of debt are recognized as a reduction in interest expense. The original discount and capitalized financing costs associated with the amounts repurchased are immaterial and are partially offsetting the gross gains on early extinguishment of debt, along with a nominal amount of transaction fees. To date under the program, the Company has repurchased $146.3 million of outstanding principal of the Senior Notes due 2031 and $21.6 million of outstanding principal of the Senior Notes due 2033.
U.S. Credit Facility
On October 4, 2023, the Company and certain of the Company’s subsidiaries entered into a Revolving Syndicated Facility Agreement (the “U.S. Credit Facility”) with CoBank, ACB as administrative agent and the other lenders party thereto. The U.S. Credit Facility provides for a revolving loan commitment of up to $850.0 million. The loan commitment matures on October 4, 2028. The U.S. Credit Facility is unsecured and will be used for general corporate purposes. Outstanding borrowings under the U.S. Credit Facility bear interest at a per annum rate equal to either the Secured Overnight Financing Rate (“SOFR”) or the prime rate plus applicable margins based on the Company’s credit ratings. As of March 30, 2025, the Company had outstanding letters of credit and available borrowings under the revolving credit commitment of $24.2 million and $825.8 million, respectively, and there were no outstanding borrowings under this agreement.
The U.S. Credit Facility requires customary financial and other covenants for transactions of this type, including limitations on 1) liens, 2) indebtedness, 3) sales and other dispositions of assets, 4) dividends, distributions, and other payments in respect of equity interest, 5) investments, and 6) voluntary prepayments, redemptions or repurchases of junior debt. In each case, clauses 1 to 6 are subject to certain exceptions which can be material and certain of such clauses only apply to the Company upon the occurrence of certain triggering events. The Company is currently in compliance with the covenants under the U.S. Credit Facility.
Europe Credit Facility
On June 24, 2022, Moy Park Holdings (Europe) Ltd. (“MPH(E)”) and other Pilgrim’s entities located in the U.K. and Republic of Ireland entered into an unsecured multicurrency revolving facility agreement (the “Europe Credit Facility”) with the Governor and Company of the Bank of Ireland, as agent, and the other lenders party thereto. The Europe Credit Facility provides for a multicurrency revolving loan commitment of up to £150.0 million. The loan commitment matures on June 24, 2027. Outstanding borrowings bear interest at the current Sterling Overnight Index Average (“SONIA”) interest rate plus 1.25%. All obligations under this agreement are guaranteed by certain of the Company’s subsidiaries. As of March 30, 2025, both the U.S. dollar-equivalent loan commitment and borrowing availability were $194.1 million and there were no outstanding borrowings under this agreement.
The Europe Credit Facility contains representations and warranties, covenants, indemnities and conditions, in each case, that the Company believes are customary for transactions of this type. Pursuant to the terms of the agreement, the Company is required to meet certain financial and other restrictive covenants. Additionally, the Company is prohibited from taking certain actions without consent of the lenders, including, without limitation, incurring additional indebtedness, entering into certain mergers or other business combination transactions, permitting liens or other encumbrances on its assets and making restricted payments, including dividends, in each case, except as expressly permitted under the Europe Credit Facility. The Company is currently in compliance with the covenants under the Europe Credit Facility.
Mexico Credit Facility
On August 15, 2023, certain of the Company’s Mexican subsidiaries entered into an unsecured credit agreement (the “Mexico Credit Facility”) with BBVA México as lender. The loan commitment under the Mexico Credit Facility is Mex$1.1 billion and can be borrowed on a revolving basis. Outstanding borrowings under the Mexico Credit Facility accrue interest at a rate equal to The Interbank Equilibrium Interest (“TIIE”) rate plus 1.35%. The Mexico Credit Facility contains covenants and defaults that the Company believes are customary for transactions of this type. The Mexico Credit Facility will be used for general corporate and working capital purposes. The Mexico Credit Facility will mature on August 15, 2026. As of March 30, 2025, the U.S. dollar-equivalent of the loan commitment and borrowing availability was $54.0 million. As of March 30, 2025, there were no outstanding borrowings under the Mexico Credit Facility. The Company is currently in compliance with the covenants under the Mexico Credit Facility.
18

Table of Contents
13. STOCKHOLDERS’ EQUITY
Accumulated Other Comprehensive Income (Loss)
The following tables provide information regarding the changes in accumulated other comprehensive loss:

| Three Months Ended March 30, 2025
| Losses Related to Foreign Currency Translation |  | Losses on Derivative Financial Instruments Classified as Cash Flow Hedges |  | Losses Related to Pension and Other Postretirement Benefits |  | Losses on Available-for-Sale Securities |  | Total
| (In thousands)
Balance, beginning of period | $ | (337,243) |  |  | $ | (2,007) |  |  | $ | (31,028) |  |  | $ | (22) |  |  | $ | (370,300) |
Other comprehensive income (loss) before reclassifications | 84,972 |  |  | 1,673 |  |  | (484) |  |  | (60) |  |  | 86,101 |
Amounts reclassified from accumulated other comprehensive loss (income) to net income | — |  |  | (10) |  |  | (60) |  |  | 41 |  |  | (29) |
Currency translation | — |  |  | (13) |  |  | 8 |  |  | — |  |  | (5) |
Net current period other comprehensive income (loss) | 84,972 |  |  | 1,650 |  |  | (536) |  |  | (19) |  |  | 86,067 |
Balance, end of period | $ | (252,271) |  |  | $ | (357) |  |  | $ | (31,564) |  |  | $ | (41) |  |  | $ | (284,233) |

| Three Months Ended March 31, 2024
| Losses Related to Foreign Currency Translation |  | Losses on Derivative Financial Instruments Classified as Cash Flow Hedges |  | Losses Related to Pension and Other Postretirement Benefits |  | Losses on Available-for-Sale Securities |  | Total
| (In thousands)
Balance, beginning of period | $ | (114,850) |  |  | $ | (1,914) |  |  | $ | (59,714) |  |  | $ | (5) |  |  | $ | (176,483) |
Other comprehensive income (loss) before reclassifications | (32,490) |  |  | 455 |  |  | 3,020 |  |  | — |  |  | (29,015) |
Amounts reclassified from accumulated other comprehensive loss (income) to net income | — |  |  | (1,041) |  |  | 106 |  |  | (6) |  |  | (941) |
Currency translation | — |  |  | 10 |  |  | 65 |  |  | — |  |  | 75 |
Net current period other comprehensive income (loss) | (32,490) |  |  | (576) |  |  | 3,191 |  |  | (6) |  |  | (29,881) |
Balance, end of period | $ | (147,340) |  |  | $ | (2,490) |  |  | $ | (56,523) |  |  | $ | (11) |  |  | $ | (206,364) |

| Amount Reclassified from Accumulated Other Comprehensive Income (Loss)(a) |  |
Details about Accumulated Other Comprehensive Income (Loss) Components | Three Months Ended March 30, 2025 |  | Three Months Ended March 31, 2024 |  | Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
| (In thousands) |  |
Realized gains on settlement of foreign currency derivatives classified as cash flow hedges | $ | (3) |  |  | $ | 1,041 |  |  | Net sales
Realized losses on settlement of foreign currency derivatives classified as cash flow hedges | 13 |  |  | — |  |  | Cost of sales
Realized gains on sale of securities | (54) |  |  | 8 |  |  | Interest income
Amortization of pension and other postretirement plan actuarial losses(b) | 80 |  |  | (140) |  |  | Miscellaneous, net
Total before tax | 36 |  |  | 909 |  |  |
Tax benefit | (7) |  |  | 32 |  |  |
Total reclassification for the period | $ | 29 |  |  | $ | 941 |  |  |

(a) Positive amounts represent income to the results of operations while amounts in parentheses represent expenses to the results of operations.
(b) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost. See “Note 14. Pension and Other Postretirement Benefits.”
19

Table of Contents
Preferred Stock
The Company has authorized 50,000,000 shares of $0.01 par value preferred stock, although no shares have been issued and no shares are outstanding.
Restrictions on Dividends
The U.S. Credit Facility and the indentures governing the Company’s senior notes have currently no restrictions on dividends. Under certain triggering events, the U.S. Credit Facility may limit the Company’s ability to declare and pay dividends. Additionally, the Europe Credit Facility may restrict MPH(E) and other Pilgrim’s entities located in the U.K. and Republic of Ireland to, among other things, make payments and distributions to the Company.
Special Cash Dividend
On March 13, 2025, the Company declared a special dividend of $6.30 per share, to stockholders of record as of April 3, 2025. On April 17, 2025, the Company paid that special dividend from retained earnings of approximately $1.5 billion. The Company used cash on hand to fund the special cash dividend.
14. PENSION AND OTHER POSTRETIREMENT BENEFITS
The Company sponsors programs that provide retirement benefits to most of its employees. These programs include qualified defined benefit pension plans in the U.K., such as the Tulip Limited Pension Plan and the Geo Adams Group Pension Fund, nonqualified defined benefit retirement plans, a defined benefit postretirement life insurance plan and defined contribution retirement savings plan. Expenses recognized under all retirement plans totaled $9.7 million and $11.2 million in the three months ended March 30, 2025 and March 31, 2024, respectively.
During 2024, the Company executed a termination of the its two U.S. pension plans, Pilgrim’s Pride Retirement Plan for Union Employees (the “Union Plan”) and the Pilgrim’s Pride Pension Plan for Legacy Gold Kist Employees (the “GK Pension Plan”). Under the plan terminations, participants were offered a lump-sum buyout or an annuity placement buyout. Assets of the pension plans were liquidated and funds from liquidation were used to settle the obligations, which amounted to $99.6 million at time of termination.
The Company used a quarter-end measurement date of March 30, 2025 for its pension and postretirement benefits plans. Certain disclosures are listed below. Other disclosures are not material to the financial statements.
Net Periodic Benefit Costs
Net defined benefit pension and other postretirement costs included the following components:

|  | Three Months Ended |  |
|  | March 30, 2025 |  | March 31, 2024 |  |  |  |
|  | Pension Benefits |  | Other Benefits |  | Pension Benefits |  | Other Benefits |  |  |  |  |  |  |  |
|  | (In thousands) |  |
Interest cost |  | $ | 1,487 |  |  | $ | 9 |  |  | $ | 2,266 |  |  | $ | 9 |  |  |  |  |  |  |  |  |
Estimated return on plan assets |  | (1,886) |  |  | — |  |  | (2,447) |  |  | — |  |  |  |  |  |  |  |  |
Expenses paid from assets |  | 125 |  |  | — |  |  | 60 |  |  | — |  |  |  |  |  |  |  |  |
Amortization of net (gain) loss |  | (84) |  |  | (1) |  |  | 136 |  |  | — |  |  |  |  |  |  |  |  |
Amortization of past service cost |  | 4 |  |  | — |  |  | 4 |  |  | — |  |  |  |  |  |  |  |  |
Net costs (income) (a) |  | $ | (354) |  |  | $ | 8 |  |  | $ | 19 |  |  | $ | 9 |  |  |  |  |  |  |  |  |

(a) Net costs are included in the line item Miscellaneous, net on the Condensed Consolidated Statements of Income.
During the three months ended March 30, 2025, the Company contributed $1.0 million to our pension programs. We anticipate making additional contributions of approximately $3.2 million during the remainder of 2025. The Company contributed $2.2 million to our pension programs during the three months ended March 31, 2024.
Remeasurement
The Company remeasures both plan assets and obligations on a quarterly basis.
20

Table of Contents
Defined Contribution Plans
The Company sponsors two defined contribution retirement savings plans in the U.S. reportable segment for eligible U.S. and Puerto Rico employees. The Company maintains three postretirement plans for eligible employees in the Mexico reportable segment, as required by Mexico law, which primarily cover termination benefits. The Company maintains seven defined contribution retirement savings plans in the Europe reportable segment for eligible U.K. and Europe employees, as required by U.K. and Europe law. The Company’s expenses related to its defined contribution plans totaled $9.4 million and $9.9 million in the three months ended March 30, 2025 and March 31, 2024, respectively.
15. FAIR VALUE MEASUREMENT
Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Assets and liabilities measured at fair value must be categorized into one of three different levels depending on the assumptions (i.e., inputs) used in the valuation:

Level 1 |  | Unadjusted quoted prices available in active markets for identical assets or liabilities at the measurement date;
Level 2 |  | Quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability; or
Level 3 |  | Unobservable inputs, such as discounted cash flow models or valuations.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement in its entirety.
As of March 30, 2025 and December 29, 2024, the Company held fixed income securities, derivative assets and derivative liabilities that were required to be measured at fair value on a recurring basis. Fixed income securities consist of investments, such as money market funds and commercial paper. Derivative assets and liabilities consist of long and short positions on exchange-traded commodity futures instruments, commodity options instruments, sales contracts instruments, foreign currency instruments to manage translation and remeasurement risk.
The following items were measured at fair value on a recurring basis:

| March 30, 2025 |  | December 29, 2024
| Level 1 |  | Level 2 |  | Total |  | Level 1 |  | Level 2 |  | Total
| (In thousands)
Assets: |  |  |  |  |  |  |  |  |  |  |
Fixed income securities | $ | 1,812,058 |  |  | $ | — |  |  | $ | 1,812,058 |  |  | $ | 1,712,917 |  |  | $ | — |  |  | $ | 1,712,917 |
Commodity derivative assets | 5,552 |  |  | — |  |  | 5,552 |  |  | 6,598 |  |  | — |  |  | 6,598 |
Foreign currency derivative assets | 1,246 |  |  | — |  |  | 1,246 |  |  | 755 |  |  | — |  |  | 755 |
Sales contract derivative assets | 1,652 |  |  | — |  |  | 1,652 |  |  | — |  |  | — |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |
Commodity derivative liabilities | (11,912) |  |  | — |  |  | (11,912) |  |  | (2,494) |  |  | — |  |  | (2,494) |
Foreign currency derivative liabilities | (237) |  |  | — |  |  | (237) |  |  | (1,397) |  |  | — |  |  | (1,397) |
Sales contract derivative liabilities | — |  |  | — |  |  | — |  |  | — |  |  | (778) |  |  | (778) |

See “Note 3. Derivative Financial Instruments” for additional information.
The valuation of financial assets and liabilities classified in Level 1 is based upon unadjusted quoted prices for identical assets or liabilities in active markets. The valuation of financial assets and liabilities in Level 2 is determined using a market approach based upon quoted prices for similar assets and liabilities in active markets or other inputs that are observable for substantially the full term of the financial instrument. The valuation of financial assets in Level 3 is determined using an income approach based on unobservable inputs such as discounted cash flow models or valuations. For each class of assets and liabilities not measured at fair value in the Condensed Consolidated Balance Sheets but for which fair value is disclosed, the Company is not required to provide the quantitative disclosure about significant unobservable inputs used in fair value measurements categorized within Level 3 of the fair value hierarchy.
In addition to the fair value disclosure requirements related to financial instruments carried at fair value, accounting standards require interim disclosures regarding the fair value of all of the Company’s financial instruments. The methods and significant assumptions used to estimate the fair value of financial instruments and any changes in methods or significant assumptions from prior periods are also required to be disclosed.
21

Table of Contents
The carrying amounts and estimated fair values of our debt obligations recorded in the Condensed Consolidated Balance Sheets consisted of the following:

| March 30, 2025 |  | December 29, 2024
| Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
| (In thousands)
Fixed-rate senior notes payable at 3.50%, at Level 2 inputs | $ | (900,000) |  |  | $ | (792,684) |  |  | $ | (900,000) |  |  | $ | (777,033) |
Fixed-rate senior notes payable at 4.25%, at Level 2 inputs | (848,568) |  |  | (804,235) |  |  | (850,342) |  |  | (789,304) |
Fixed-rate senior notes payable at 6.25%, at Level 2 inputs | (972,976) |  |  | (1,015,239) |  |  | (974,381) |  |  | (1,001,178) |
Fixed-rate senior notes payable at 6.875%, at Level 2 inputs | (491,560) |  |  | (538,600) |  |  | (491,329) |  |  | (533,650) |
Live Oak CHP Project PACE Loan at 5.15%, at Level 3 inputs | (18,478) |  |  | (18,935) |  |  | (20,599) |  |  | (18,569) |

See “Note 12. Debt” for additional information.
The carrying amounts of our cash and cash equivalents, restricted cash and restricted cash equivalents, accounts receivable, accounts payable and certain other liabilities approximate their fair values due to their relatively short maturities. Derivative assets were recorded at fair value based on quoted market prices and are included in the line item Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets. Derivative liabilities were recorded at fair value based on quoted market prices and are included in the line item Accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheets. The fair value of the Company’s Level 2 fixed-rate debt obligations was based on the quoted market price at March 30, 2025 or December 29, 2024, as applicable.
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges when required by U.S. GAAP. There were no significant fair value measurement losses recognized for such assets and liabilities in the periods reported.
22

Table of Contents
16. RESTRUCTURING-RELATED ACTIVITIES
In 2022, the Company began restructuring initiatives in its Europe reportable segment. Additional restructuring initiatives also commenced in 2023 and 2024. The purpose of our ongoing restructuring activities is to integrate central operations and reallocate processing capacities between production facilities resulting in closures of some facilities in the Europe reportable segment.
The following table provides a summary of our estimates of timelines and costs associated with these restructuring initiatives by major type of cost:

| Pilgrim’s Food Masters 2024 |  | Pilgrim’s Europe Central |  | Total
| (In thousands)
Earliest implementation date | April 2024 |  | January 2024 |  |
Expected predominant completion date | March 2025 |  | June 2025 |  |
Costs incurred and expected to be incurred |  |  |  |  |
Employee-related costs | $ | 19,760 |  |  | $ | 49,202 |  |  | $ | 68,962 |
Asset impairment costs | 10,871 |  |  | 1,824 |  |  | 12,695 |
Contract termination costs | 855 |  |  | 1,747 |  |  | 2,602 |
Other exit and disposal costs (a) | 10,580 |  |  | 3,633 |  |  | 14,213 |
Total exit and disposal costs (b) | $ | 42,066 |  |  | $ | 56,406 |  |  | $ | 98,472 |
Costs incurred since earliest implementation date |  |  |  |  |
Employee-related costs | $ | 19,760 |  |  | $ | 40,144 |  |  | $ | 59,904 |
Asset impairment costs | 10,871 |  |  | 1,824 |  |  | 12,695 |
Contract termination costs | 855 |  |  | 1,747 |  |  | 2,602 |
Other exit and disposal costs (a) | 10,580 |  |  | 3,633 |  |  | 14,213 |
Total exit and disposal costs | $ | 42,066 |  |  | $ | 47,348 |  |  | $ | 89,414 |

(a)Comprised of other costs directly related to the restructuring initiatives including flock depletion, the write-off of prepaid maintenance costs, consulting fees, and costs to return leased assets to original configuration.
(b)All costs, except for asset impairment costs, are estimated to result in cash outlays.
During the three months ended March 30, 2025, the Company recognized the following expenses and paid the following cash related to each restructuring initiative:

| Expenses |  | Cash Outlays
| (In thousands)
Pilgrim’s Food Masters 2024 | $ | 1,331 |  |  | $ | 2,951 |
Pilgrim’s Europe Central | 14,655 |  |  | 1,813 |
Prior programs substantially complete | 626 |  |  | 621 |
Total | $ | 16,612 |  |  | $ | 5,385 |

These expenses are reported in the line item Restructuring activities on the Condensed Consolidated Statements of Income.
The following table reconciles liabilities and reserves associated with each restructuring initiative during the three months ended March 30, 2025. Ending liability balances for employee termination benefits and other charges are reported in the line item Accrued expenses and other current liabilities in our Condensed Consolidated
23

Table of Contents
Balance Sheets. The ending reserve balance for inventory adjustments is reported in the line item Inventories in our Condensed Consolidated Balance Sheets. During the three months ended March 30, 2025, there were no material movements in reserves related to substantially completed programs. These programs have been excluded from the tables below.

| Pilgrim’s Food Masters 2024
| Liability or reserve as of December 29, 2024 |  | Restructuring charges incurred |  | Cash payments and disposals |  | Currency translation |  | Liability or reserve as of March 30, 2025
| (In thousands)
Employee retention benefits | $ | 76 |  |  | $ | 244 |  |  | $ | (298) |  |  | $ | 2 |  |  | $ | 24 |
Severance | 1,620 |  |  | (112) |  |  | (445) |  |  | 32 |  |  | 1,095 |
Asset impairment | — |  |  | 63 |  |  | (63) |  |  | — |  |  | — |
Inventory adjustments | — |  |  | (34) |  |  | 34 |  |  | — |  |  | — |
Lease termination | 290 |  |  | 6 |  |  | (6) |  |  | 8 |  |  | 298 |
Other charges | 4,787 |  |  | 1,164 |  |  | (2,208) |  |  | 110 |  |  | 3,853 |
Total | $ | 6,773 |  |  | $ | 1,331 |  |  | $ | (2,986) |  |  | $ | 152 |  |  | $ | 5,270 |

| Pilgrim’s Europe Central
| Liability or reserve as of December 29, 2024 |  | Restructuring charges incurred |  | Cash payments and disposals |  | Currency translation |  | Liability or reserve as of March 30, 2025
| (In thousands)
Severance | $ | 2,823 |  |  | $ | 12,188 |  |  | $ | (1,813) |  |  | $ | 365 |  |  | $ | 13,563 |
Inventory adjustments | 91 |  |  | — |  |  | — |  |  | 3 |  |  | 94 |
Lease termination | — |  |  | 2,042 |  |  | — |  |  | 56 |  |  | 2,098 |
Other charges | 67 |  |  | 425 |  |  | — |  |  | 15 |  |  | 507 |
Contract termination | 1,223 |  |  | — |  |  | — |  |  | 35 |  |  | 1,258 |
Total | $ | 4,204 |  |  | $ | 14,655 |  |  | $ | (1,813) |  |  | $ | 474 |  |  | $ | 17,520 |

24

Table of Contents
17. RELATED PARTY TRANSACTIONS
Pilgrim’s has been and, in some cases, continues to be a party to certain transactions with affiliated companies.

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Sales to related parties |  |  |
JBS Toledo N.V. | $ | 10,115 |  |  | $ | — |
JBS USA Food Company(a) | 4,817 |  |  | 5,374 |
Other related parties | 293 |  |  | 1,757 |
Total | $ | 15,225 |  |  | $ | 7,131 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Cost of goods purchased from related parties |  |  |
JBS USA Food Company(a) | $ | 36,492 |  |  | $ | 40,324 |
Seara Meats B.V. | 26,670 |  |  | 5,395 |
Penasul UK LTD | 9,658 |  |  | 3,530 |
JBS Asia Co Limited | 2,268 |  |  | 863 |
Other related parties | 711 |  |  | 498 |
Total | $ | 75,799 |  |  | $ | 50,610 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Expenditures paid by related parties |  |  |
JBS USA Food Company(b) | $ | 18,090 |  |  | $ | 17,771 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Expenditures paid on behalf of related parties |  |  |
JBS USA Food Company(b) | $ | 4,518 |  |  | $ | 2,689 |

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Accounts receivable from related parties |  |  |
JBS Toledo N.V. | $ | 6,613 |  |  | $ | — |
JBS USA Food Company(a) | 3,837 |  |  | 1,727 |
JBS Chile Ltda. | 20 |  |  | 725 |
Other related parties | 142 |  |  | 156 |
Total | $ | 10,612 |  |  | $ | 2,608 |

25

Table of Contents

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Accounts payable to related parties |  |  |
Seara Meats B.V. | $ | 19,381 |  |  | $ | 4,861 |
JBS USA Food Company(a) | 3,198 |  |  | 5,424 |
JBS Asia Co Limited | 2,160 |  |  | 4,023 |
Other related parties | 2,541 |  |  | 949 |
Total | $ | 27,280 |  |  | $ | 15,257 |

(a)The Company routinely executes transactions to both purchase products from JBS USA Food Company (“JBS USA”) and sell products to them. As of March 30, 2025, goods purchased and in transit from JBS USA were immaterial and not reflected on our Consolidated Balance Sheets.
(b)The Company has an agreement with JBS USA to allocate costs associated with JBS USA’s procurement of SAP licenses and maintenance services for both companies. Under this agreement, the fees associated with procuring SAP licenses and maintenance services are allocated between the Company and JBS USA in proportion to the percentage of licenses used by each company. The agreement expires on the date of expiration, or earlier termination, of the underlying SAP license agreement. The Company also has an agreement with JBS USA to allocate the costs of supporting the business operations by one consolidated corporate team, which have historically been supported by their respective corporate teams. Expenditures paid by JBS USA on behalf of the Company will be reimbursed by the Company and expenditures paid by the Company on behalf of JBS USA will be reimbursed by JBS USA. This agreement expires on December 31, 2025.
18. REPORTABLE SEGMENTS
The Company operates in three reportable segments: U.S., Europe, and Mexico. The Company’s reportable segments are identified by a combination of factors, including geographic area, regulatory environment, economic environment and product portfolios. Each reportable segment is managed separately through a local management team. The results of each operating, or reportable, segment are provided to the chief operating decision maker (“CODM”) on a regular basis. The Company’s CODM is the President and Chief Executive Officer. The information provided to the CODM at the operating segment level is then used to assess performance and make decisions regarding allocation of key resources. The CODM primarily measures segment profit and evaluates performance based on operating income.
We conduct separate operations in the continental U.S. and in Puerto Rico. For segment reporting purposes, the Puerto Rico operations are included in the U.S. reportable segment. The chicken products processed by the U.S. reportable segment are sold to foodservice, retail and frozen entrée customers. The segment’s primary distribution is through retailers, foodservice distributors and restaurants.
The Europe reportable segment processes primarily fresh chicken, pork products, lamb products, specialty meats, ready meals and other prepared foods that are sold to foodservice, retail and direct to consumer customers. The segment’s primary distribution is through retailers, foodservice distributors and restaurants.
The chicken products processed by the Mexico reportable segment are sold to foodservice, retail and frozen entrée customers. The segment’s primary distribution is through retailers, foodservice distributors and restaurants.
Additional information regarding reportable segments is as follows:

| Three Months Ended
| March 30, 2025(a) |  | March 31, 2024(b)
| (In thousands)
Net sales |  |  |
U.S. | $ | 2,743,189 |  |  | $ | 2,579,332 |
Europe | 1,231,529 |  |  | 1,267,903 |
Mexico | 488,291 |  |  | 514,699 |
Total net sales | $ | 4,463,009 |  |  | $ | 4,361,934 |

(a)In addition to the above third party sales, for the three months ended March 30, 2025, the U.S. reportable segment had intercompany sales to the Mexico reportable segment of $27.7 million. These sales consisted of fresh products, prepared products and grain.
(b)In addition to the above third party sales, for the three months ended March 31, 2024, the U.S. reportable segment had intercompany sales to the Mexico reportable segment of $47.9 million. These sales consisted of fresh products, prepared products and grain.
26

Table of Contents

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Cost of sales |  |  |
U.S. | $ | 2,355,567 |  |  | $ | 2,342,040 |
Europe | 1,115,225 |  |  | 1,175,738 |
Mexico | 437,344 |  |  | 460,247 |
Total cost of sales | $ | 3,908,136 |  |  | $ | 3,978,025 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Gross profit |  |  |
U.S. | $ | 387,622 |  |  | $ | 237,292 |
Europe | 116,304 |  |  | 92,165 |
Mexico | 50,947 |  |  | 54,452 |
Total gross profit | $ | 554,873 |  |  | $ | 383,909 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Selling, general administrative expenses |  |  |
U.S. | $ | 68,816 |  |  | $ | 57,875 |
Europe | 50,621 |  |  | 46,490 |
Mexico | 14,342 |  |  | 14,711 |
Total SG&A expenses | $ | 133,779 |  |  | $ | 119,076 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Restructuring activities charges |  |  |
Europe | $ | 16,612 |  |  | $ | 14,559 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Operating income |  |  |
U.S. | $ | 318,806 |  |  | $ | 179,417 |
Europe | 49,071 |  |  | 31,116 |
Mexico | 36,605 |  |  | 39,741 |
Total operating income | $ | 404,482 |  |  | $ | 250,274 |

27

Table of Contents

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Reconciliation of profit or loss (segment operating income) |  |  |
Total operating income | $ | 404,482 |  |  | $ | 250,274 |
Interest expense, net of capitalized interest | 41,738 |  |  | 41,243 |
Interest income | (24,953) |  |  | (10,346) |
Foreign currency transaction gains | (2,053) |  |  | (4,337) |
Miscellaneous, net | (692) |  |  | (3,286) |
Income before income taxes | 390,442 |  |  | 227,000 |
Income tax expense | 94,099 |  |  | 52,062 |
Net income | $ | 296,343 |  |  | $ | 174,938 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Interest expense |  |  |
U.S. | $ | 41,213 |  |  | $ | 46,335 |
Europe | 377 |  |  | 494 |
Mexico | 148 |  |  | 131 |
Eliminations | — |  |  | (5,717) |
Total interest expense | $ | 41,738 |  |  | $ | 41,243 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Interest income |  |  |
U.S. | $ | (15,646) |  |  | $ | (1,749) |
Europe | (2,281) |  |  | (2,477) |
Mexico | (7,026) |  |  | (11,837) |
Eliminations | — |  |  | 5,717 |
Total interest income | $ | (24,953) |  |  | $ | (10,346) |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Income tax expense |  |  |
U.S. | $ | 71,012 |  |  | $ | 32,060 |
Europe | 9,922 |  |  | 9,557 |
Mexico | 13,165 |  |  | 10,445 |
Total income tax expense | $ | 94,099 |  |  | $ | 52,062 |

28

Table of Contents

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Depreciation and amortization |  |  |
U.S. | $ | 66,386 |  |  | $ | 62,685 |
Europe | 33,137 |  |  | 35,028 |
Mexico | 4,995 |  |  | 5,637 |
Total depreciation and amortization | $ | 104,518 |  |  | $ | 103,350 |

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Capital expenditures(a) |  |  |
U.S. | $ | 71,927 |  |  | $ | 78,631 |
Europe | 21,664 |  |  | 17,141 |
Mexico | 5,199 |  |  | 3,296 |
Total capital expenditures | $ | 98,790 |  |  | $ | 99,068 |

(a)Capital expenditures incurred include those that were paid out in cash and those that are still outstanding in accounts payable as of March 30, 2025.

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Total assets |  |  |
U.S. | $ | 7,986,902 |  |  | $ | 7,848,510 |
Europe | 4,143,997 |  |  | 4,051,150 |
Mexico | 1,184,975 |  |  | 1,172,728 |
Eliminations | (2,352,115) |  |  | (2,421,812) |
Total assets | $ | 10,963,759 |  |  | $ | 10,650,576 |

| March 30, 2025 |  | December 29, 2024
| (In thousands)
Long-lived assets(a) |  |  |
U.S. | $ | 2,157,951 |  |  | $ | 2,156,858 |
Europe | 992,394 |  |  | 979,116 |
Mexico | 263,035 |  |  | 261,518 |
Eliminations | (3,888) |  |  | (3,888) |
Total long-lived assets | $ | 3,409,492 |  |  | $ | 3,393,604 |

(a)For this disclosure, we exclude financial instruments, deferred tax assets and intangible assets in accordance with ASC 280-10-50-41, Segment Reporting. Long-lived assets, as used in ASC 280-10-50-41, implies hard assets that cannot be readily removed.

| Three Months Ended
| March 30, 2025 |  | March 31, 2024
| (In thousands)
Net sales to customers by customer location |  |  |
U.S. | $ | 2,635,699 |  |  | $ | 2,471,216 |
Europe | 1,212,977 |  |  | 1,258,620 |
Mexico | 498,744 |  |  | 526,157 |
Asia-Pacific | 75,526 |  |  | 71,491 |
Canada, Caribbean and Central America | 18,188 |  |  | 16,158 |
Africa | 14,882 |  |  | 13,672 |
South America | 6,993 |  |  | 4,620 |
Total | $ | 4,463,009 |  |  | $ | 4,361,934 |

29

Table of Contents
Information regarding net sales attributable to each of our primary product lines and markets served with those products is included in "Note 2. Revenue Recognition." We based the table on our internal sales reports and their classification of products.
19. COMMITMENTS AND CONTINGENCIES
General
The Company is a party to many routine contracts in which it provides general indemnities in the normal course of business to third parties for various risks. Among other considerations, the Company has not recorded a liability for any of these indemnities because, based upon the likelihood of payment, the fair value of such indemnities would not have a material impact on its financial condition, results of operations and cash flows.
Financial Instruments
The Company’s loan agreements generally obligate the Company to reimburse the applicable lender for incremental increased costs due to a change in law that imposes (1) any reserve or special deposit requirement against assets of, deposits with or credit extended by such lender related to the loan, (2) any tax, duty or other charge with respect to the loan (except standard income tax) or (3) capital adequacy requirements. In addition, some of the Company’s loan agreements contain a withholding tax provision that requires the Company to pay additional amounts to the applicable lender or other financing party, generally if withholding taxes are imposed on such lender or other financing party as a result of a change in the applicable tax law. These increased cost and withholding tax provisions continue for the entire term of the applicable transaction and there is no limitation on the maximum additional amounts the Company could be obligated to pay under such provisions. Any failure to pay amounts due under such provisions generally would trigger an event of default and, in a secured financing transaction, would entitle the lender to foreclose upon the collateral to realize the amount due.
Litigation
The Company is subject to various legal proceedings and claims which arise in the ordinary course of business. In the Company’s opinion, it has made appropriate and adequate accruals for claims where necessary; however, the ultimate liability for these matters is uncertain, and if significantly different than the amounts accrued, the ultimate outcome could have a material effect on the financial condition or results of operations of the Company. The Company cannot predict the outcome of the litigation matters or other actions nor when they will be resolved. The consequences of the pending litigation matters are inherently uncertain, and settlements, adverse actions, or adverse judgments in some or all of these matters, including investigations by the U.S. Department of Justice (“DOJ”) or the Attorneys General, may result in monetary damages, fines, penalties, or injunctive relief against the Company, which could be material and could adversely affect its financial condition or results of operations. Any claims or litigation, even if fully indemnified or insured, could damage the Company’s reputation and make it more difficult to compete effectively or to obtain adequate insurance in the future. In addition, the U.S. government’s recent focus on market dynamics in the meat processing industry could expose the Company to additional costs and risks.
The disclosures defined or referenced in Note 21 to the consolidated financial statements included in Item 8 of the Annual Report on Form 10-K for the fiscal year ended December 29, 2024 as the “Broiler Antitrust Litigation,” Hogan v., Pilgrim’s Pride Corporation et al., the Mexican Tax Administration Service’s assessments in connection with PPC’s acquisition of Tyson de México, and the U.K. Revenue & Customs Authority’s review of the 2017 and 2018 tax returns for Onix Investments UK Ltd are hereby incorporated by reference herein, as supplemented by the following disclosures:
“Broiler Antitrust Litigation”
On February 11, 2025, motions to dismiss Phase 2 of the Broiler Antitrust Litigation that had been filed by PPC and other defendants were denied. PPC will seek reasonable settlements with the Broiler Opt Outs where they are available. To date, PPC has incurred expenses of $583.8 million, including an immaterial incremental increase in the three months ended March 30, 2025 to cover settlements with various Broiler Opt Outs.
Hogan v. Pilgrim’s Pride Corporation, et al.
On February 5, 2025 the settlement agreement received preliminary court approval. During 2024, PPC accrued an expense of $41.5 million, which remains unpaid.
Mexican Tax Administration Service’s tax assessments in connection with PPC’s 2015 acquisition of Tyson de México
On February 7, 2025, the Collegiate (appellate) court issued a decision remanding the dispute to the Tax Court. On March 19, 2025, the Tax Court ruled that, for tax purposes and with respect to both assessments, the sale of the equity of
30

Table of Contents
Provemex occurred on June 29, 2015, and that Provemex was a Mexican tax resident on that date. PPC appealed this ruling to the Collegiate court on April 23, 2025 and will continue to defend this matter. The amount under appeal for the assessment, including any penalties and interest, is approximately $269.5 million. No expense has been recorded for this amount at this time.
U.K. Revenue & Customs Authority’s review of the 2017 and 2018 tax returns for Onix Investments UK Ltd
On March 10, 2025, HMRC filed their Statement of Case (a preliminary summary of arguments). A case management timetable has been agreed between Onix and HMRC and will be presented to the court for approval. Onix will continue to defend this matter.
31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Executive Summary
Overview
Pilgrim’s Pride Corporation (referred to herein as “Pilgrim’s,” “PPC,” “the Company,” “we,” “us,” “our,” or similar terms) is one of the largest chicken producers in the world, with operations in the United States (“U.S.”), the United Kingdom (“U.K.”), Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. We reported net income attributable to Pilgrim’s of $296.0 million, or $1.24 per diluted common share, and income before tax totaling $390.4 million, for the three months ended March 30, 2025. These operating results included net sales of $4.5 billion, gross profit of $554.9 million and $126.9 million of cash provided by operating activities. We generated a consolidated operating margin of 9.1%. For the three months ended March 30, 2025, we generated EBITDA and Adjusted EBITDA of $511.7 million and $533.2 million, respectively. A reconciliation of net income to EBITDA and Adjusted EBITDA is included below.
Global Economic Conditions
During the first quarter of 2025, global inflation levels declined though projections for the remainder of 2025 vary due to elevated policy uncertainty. U.S. inflation decreased during the first quarter of 2025 driven primarily by lower gasoline prices. The U.K. and E.U. region saw a continued decrease in inflation rate, however the U.K. labor cost index rose during the first quarter of 2025. The Russia-Ukraine war's impact on the global feed ingredient and energy markets is currently less pronounced though there remain many risks and uncertainties that may impact global markets. In Mexico, inflation increased slightly during the first quarter of 2025 partially driven by increased food prices. The peso weakened slightly against the U.S. dollar when comparing the end of first quarter of 2025 to the end of 2024.
We have responded to these challenges by continuing negotiations with customers to mitigate the impact of extraordinary costs we have experienced. We also continue to focus on operational initiatives that aim to deliver labor efficiencies, better agricultural performance and improved yields.
Raw Materials and Pricing
Our U.S. and Mexico segments use corn and soybean meal as the main ingredients for feed production, while our Europe segment uses wheat, soybean meal and barley as the main ingredients for feed production. The following table reflects the highest and lowest prices reached on nearby futures for one bushel of corn, one ton of soybean meal, and one metric ton of wheat during the current and previous years:

| Corn(a) |  | Soybean Meal(a) |  | Wheat(a)
| Highest Price |  | Lowest Price |  | Highest Price |  | Lowest Price |  | Highest Price |  | Lowest Price
| (In whole dollars) |  | (In whole pounds sterling)
2025 |  |  |  |  |  |  |  |  |  |  |
First Quarter | 5.02 |  |  | 4.36 |  |  | 315.8 |  |  | 285.9 |  |  | 185.6 |  |  | 165.0 |
2024 |  |  |  |  |  |  |  |  |  |  |
Fourth Quarter | 4.54 |  |  | 4.01 |  |  | 350.0 |  |  | 279.5 |  |  | 190.5 |  |  | 174.0 |
Third Quarter | 4.18 |  |  | 3.62 |  |  | 387.0 |  |  | 303.4 |  |  | 196.9 |  |  | 168.7 |
Second Quarter | 4.65 |  |  | 3.97 |  |  | 386.5 |  |  | 328.3 |  |  | 202.8 |  |  | 165.1 |
First Quarter | 4.67 |  |  | 4.00 |  |  | 381.2 |  |  | 327.8 |  |  | 184.5 |  |  | 153.7 |

(a)We obtain corn and soybean meal prices from the Chicago Board of Trade, and we obtain wheat prices from the London International Financial Futures and Options Exchange.
U.S. commodity market prices for chicken products trended above the historical five-year average and above the prior year average through first quarter, primarily driven by rapid increases in boneless breast pricing that greatly exceeded normal seasonal movements. Per the April 2025 U.S. Department of Agriculture (or “USDA”) report on poultry slaughter, estimated industry ready-to-cook production during the first quarter of 2025 was 1.1% above prior year levels primarily due to heavier average liveweights.
During the first quarter of 2025, the U.S. chicken market experienced firm volume demand, supported by growth in the retail distribution channel and steady foodservice channel demand. The total domestic demand growth continued to outpace supply. Export volume in shipments were lower than the five-year historical average for the first quarter of 2025,
32

though demand continues to support stable pricing for export product types. Chicken cold storage inventories ended the quarter 3.1% above prior year levels and 3% below the historical five-year average.
During the first quarter of 2025, the U.K. chicken market volume was higher than in the same quarter of the prior year. U.K. imports of European chicken are increasing slightly from strong consumer demand in the U.K., though Europe market prices have increased due to strong consumer demand in the European market. In the U.K., prices were more stable due to stable grain prices in Q1 2025 compared to Q1 2024, despite some production constraints from switching to higher welfare birds.
Commodity prices for chicken in Mexico decreased during the first quarter of 2025, though were above the average prior year prices. Market corn prices in Mexico were higher than the same quarter in the prior year though lower than the historical five-year average price levels. Soybean meal prices in Mexico decreased throughout the first quarter of 2025, but ended the quarter higher than the prior year levels.
U.K. market prices for pork products faced downward pressure throughout the first quarter of 2025 due to the price differential between U.K. and E.U. pork prices. E.U. pork prices fell this period, primarily because of a foot and mouth disease outbreak in Germany, which limited exports. To compensate, non-German pork products saw an increase.
U.K. pig production rose by approximately 6.4% in the first quarter of 2025 compared to the same period last year, according to the U.K. Agriculture and Horticulture Development Board. This increase was mainly driven by a higher pig kill rate, with increased weights having a minor impact.
Additionally, U.K. prices for pork finished products and prepared foods increased during the first quarter of 2025 due to inflationary pressures, primarily from higher feed prices, regulatory changes, and increased labor costs.
Global market prices for the remainder of the year will depend on (1) the evolution of foodservice, retail and export meat demand and (2) factors such as feed production input costs, further spread of avian influenza, or other bird diseases, both domestically and abroad, uncertainty surrounding the general economy and overall protein supply.
Special Cash Dividend
On March 13, 2025, the Company declared a special dividend of $6.30 per share, to stockholders of record as of April 3, 2025. On April 17, 2025, the Company paid that special dividend from retained earnings of approximately $1.5 billion. The Company used cash on hand to fund the special cash dividend.
Reportable Segments
We operate in three reportable segments: U.S., Europe, and Mexico. We measure segment profit as operating income. Certain corporate expenses are allocated to the Mexico and Europe reportable segments based upon various apportionment methods for specific expenditures incurred related thereto with the remaining amounts allocated to the U.S. For additional information, see “Note 18. Reportable Segments” of our Condensed Consolidated Financial Statements included in this quarterly report.
Three Months Ended March 30, 2025 Compared to the Three Months Ended March 31, 2024
Net sales. Net sales generated in the three months ended March 30, 2025 increased $101.1 million, or 2.3%, from net sales generated in the three months ended March 31, 2024. The following table provides net sales information:

Sources of net sales |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |  | Impact on Change from Three Months Ended March 31, 2024
Amount |  | Percent |  | Sales Volume | Sales Prices | Foreign Currency Translation Impact
|  | (In thousands, except percent data) |  | (In percent)
U.S. |  | $ | 2,743,189 |  |  | $ | 163,857 |  |  | 6.4 | % |  | 1.9 | % | 4.5 | % | — | %
Europe |  | 1,231,529 |  |  | (36,374) |  |  | (2.9) | % |  | (2.1) | % | (0.1) | % | (0.7) | %
Mexico |  | 488,291 |  |  | (26,408) |  |  | (5.1) | % |  | 0.4 | % | 13.8 | % | (19.3) | %
Total net sales |  | $ | 4,463,009 |  |  | $ | 101,075 |  |  | 2.3 | % |  |  |  |

U.S. Reportable Segment. U.S. net sales generated in the three months ended March 30, 2025 increased $163.9 million, or 6.4%, from U.S. net sales generated in the three months ended March 31, 2024 primarily due to an increase
33

in net sales per pound and an increase in sales volume of $115.8 million, or 4.5 percentage points, and $48.1 million, or 1.9 percentage points, respectively. The increase in net sales per pound was driven primarily by favorable market pricing conditions and shift in consumer demand to higher value products.
Europe Reportable Segment. E urope net sales generated in the three months ended March 30, 2025 decreased $36.4 million, or 2.9%, from Europe net sales generated in the three months ended March 31, 2024 primarily due to a decrease in sales volume, the unfavorable impact of foreign currency translation, and net sales per pound of $26.2 million, or 2.1 percentage points, $9.2 million, or 0.7 percentage points, and $1.0 million, or 0.1 percentage points, respectively. The decrease in sales volume was primarily across the retail channel, though was partially offset by increases in the foodservice channel. The decrease in net sales per pound was primarily due to the structure of certain customer contracts impacted by lower input costs.
Mexico Reportable Segment. Mexico net sales generated in the three months ended March 30, 2025 decreased $26.4 million, or 5.1%, from Mexico net sales generated in the three months ended March 31, 2024 primarily due to the unfavorable impact of foreign currency translation of $99.4 million, or 19.3 percentage points. The decrease in net sales was partially offset by increases in net sales per pound and sales volume of $71.0 million, or 13.8 percentage points, and $2.0 million, or 0.4 percentage points, respectively. The decrease due to the unfavorable impact of foreign currency translation was driven by a year-over-year depreciation of 20% in the Mexican peso against the U.S. dollar due to inflation in the Mexican economy, along with uncertainties impacting the exchange rate. The increase in price per pound sold was driven by an increase in commodity chicken pricing due to increased local consumer demand and lower supply due to bird disease.
Gross profit and cost of sales. Gross profit increased by $171.0 million from $383.9 million generated in the three months ended March 31, 2024 to $554.9 million generated in the three months ended March 30, 2025. The following tables provide information regarding gross profit and cost of sales information:

Components of gross profit |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |  | Percent of Net Sales |
|  | Three Months Ended |
| Amount |  | Percent |  | March 30, 2025 |  | March 31, 2024 |
|  | (In thousands, except percent data) |
Net sales |  | $ | 4,463,009 |  |  | $ | 101,075 |  |  | 2.3 | % |  | 100.0 | % |  | 100.0 | % |
Cost of sales |  | 3,908,136 |  |  | (69,889) |  |  | (1.8) | % |  | 87.6 | % |  | 91.2 | % |
Gross profit |  | $ | 554,873 |  |  | $ | 170,964 |  |  | 44.5 | % |  | 12.4 | % |  | 8.8 | % |

Sources of gross profit |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |
Amount |  | Percent |
|  | (In thousands, except percent data) |
U.S. |  | $ | 387,622 |  |  | $ | 150,330 |  |  | 63.4 | % |
Europe |  | 116,304 |  |  | 24,139 |  |  | 26.2 | % |
Mexico |  | 50,947 |  |  | (3,505) |  |  | (6.4) | % |
Elimination |  | — |  |  | — |  |  | N/A |
Total gross profit |  | $ | 554,873 |  |  | $ | 170,964 |  |  | 44.5 | % |

Sources of cost of sales |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |
Amount |  | Percent |
|  | (In thousands, except percent data) |
U.S. |  | $ | 2,355,567 |  |  | $ | 13,527 |  |  | 0.6 | % |
Europe |  | 1,115,225 |  |  | (60,513) |  |  | (5.1) | % |
Mexico |  | 437,344 |  |  | (22,903) |  |  | (5.0) | % |
Elimination |  | — |  |  | — |  |  | N/A |
Total cost of sales |  | $ | 3,908,136 |  |  | $ | (69,889) |  |  | (1.8) | % |

34

U.S. Reportable Segment. Cost of sales incurred by our U.S. operations during the three months ended March 30, 2025 increased $13.5 million, or 0.6%, from cost of sales incurred by our U.S. segment during the three months ended March 31, 2024. The increase in cost of sales was primarily driven by an increase in sales volume of $43.6 million, or 1.9 percentage points, partially offset by a decrease in cost per pound sold of $30.1 million, or 1.3 percentage points. The increase in sales volume was driven by consumer demand. The decrease from prior year in cost per pound sold is primarily due to declining feed ingredients costs, specifically soybean meal which decreased approximately 25% from prior year levels.
Europe Reportable Segment. Cost of sales incurred by our Europe operations during the three months ended March 30, 2025 decreased $60.5 million, or 5.1%, from cost of sales incurred by our Europe segment during the three months ended March 31, 2024. The decrease in cost of sales was primarily driven by a decrease in cost per pound sold, sales volume, and the favorable impact of foreign currency translation of $27.7 million, or 2.3 percentage points, $24.3 million, or 2.1 percentage points, and $8.5 million, or 0.7 percentage points, respectively. The decrease in cost per pound sold was driven by lower labor costs, feed ingredients, labor, utilities and other operating costs, some of which was driven by the recent restructuring initiatives throughout the Europe reportable segment. The decrease in sales volume was primarily across the retail channel, though was partially offset by increases in the foodservice channel.
Mexico Reportable Segment. Cost of sales incurred by our Mexico operations during the three months ended March 30, 2025 decreased $22.9 million, or 5.0%, from cost of sales incurred by our Mexico segment during the three months ended March 31, 2024.The decrease in cost of sales was driven by the favorable impact of foreign currency translation. As noted above, there was a year-over-year depreciation of 20% in the Mexican peso against the U.S. dollar. This decrease was partially offset by an increase in cost per pound sold and sales volume of $64.4 million, or 14.0 percentage points, and $1.8 million, or 0.4 percentage points, respectively. The increase in cost per pound sold was driven by an increase in year-over-year market prices of commodity ingredients, such as corn.
Operating income and SG&A expense. Operating income increased by $154.2 million, or 61.6%, from income of $250.3 million generated in the three months ended March 31, 2024 to income of $404.5 million generated in the three months ended March 30, 2025. The following tables provide information regarding operating income and selling, general and administrative (“SG&A”) expense:

Components of operating income |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |  | Percent of Net Sales |
Three Months Ended |
Amount |  | Percent |  | March 30, 2025 |  | March 31, 2024 |
|  | (In thousands, except percent data) |
Gross profit |  | $ | 554,873 |  |  | $ | 170,964 |  |  | 44.5 | % |  | 12.4 | % |  | 8.8 | % |
SG&A expense |  | 133,779 |  |  | 14,703 |  |  | 12.3 | % |  | 3.0 | % |  | 2.7 | % |
Restructuring activities |  | 16,612 |  |  | 2,053 |  |  | 14.1 | % |  | 0.4 | % |  | 0.3 | % |
Operating income |  | $ | 404,482 |  |  | $ | 154,208 |  |  | 61.6 | % |  | 9.1 | % |  | 5.7 | % |

Sources of operating income |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |
Amount |  | Percent |
|  | (In thousands, except percent data) |
U.S. |  | $ | 318,806 |  |  | $ | 139,389 |  |  | 77.7 | % |
Europe |  | 49,071 |  |  | 17,955 |  |  | 57.7 | % |
Mexico |  | 36,605 |  |  | (3,136) |  |  | (7.9) | % |
Total operating income |  | $ | 404,482 |  |  | $ | 154,208 |  |  | 61.6 | % |
Sources of SG&A expense |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024 |
Amount |  | Percent |
|  | (In thousands, except percent data) |
U.S. |  | $ | 68,816 |  |  | $ | 10,941 |  |  | 18.9 | % |
Europe |  | 50,621 |  |  | 4,131 |  |  | 8.9 | % |
Mexico |  | 14,342 |  |  | (369) |  |  | (2.5) | % |
Total SG&A expense |  | $ | 133,779 |  |  | $ | 14,703 |  |  | 12.3 | % |

35

Sources of restructuring activities charges |  | Three Months Ended March 30, 2025 |  | Change from Three Months Ended March 31, 2024
Amount |  | Percent
|  | (In thousands, except percent data)
Europe |  | $ | 16,612 |  |  | $ | 2,053 |  |  | 14.1 | %

U.S. Reportable Segment. SG&A expense incurred by our U.S. reportable segment during the three months ended March 30, 2025 increased $10.9 million, or 18.9%, from SG&A expense incurred by our U.S. reportable segment during the three months ended March 31, 2024. The increase in SG&A expense resulted primarily from an increase in legal settlement expense, incentive compensation costs, and legal defense costs.
Europe Reportable Segment. SG&A expense incurred by our Europe reportable segment during the three months ended March 30, 2025 increased $4.1 million, or 8.9%, from SG&A expense incurred by our Europe segment during the three months ended March 31, 2024. The increase in SG&A expense was primarily due to increases in incentive compensation costs and software license fees.
Mexico Reportable Segment. SG&A expense incurred by our Mexico reportable segment during the three months ended March 30, 2025 decreased $0.4 million, or 2.5%, from SG&A expense incurred by our Mexico segment during the three months ended March 31, 2024. The primary driver of the decrease in SG&A expense was the favorable impact of foreign currency translation due to the year-over-year depreciation of the Mexican peso against the U.S. dollar. This decrease was partially offset by increases in payroll and marketing costs.
Restructuring activities. Restructuring activities costs of $16.6 million were recognized in the three months ended March 30, 2025. These charges were incurred by our Europe reportable segment primarily as a result of severance and warehouse closure costs.
Net interest expense. Net interest expense decreased to $16.8 million recognized in the three months ended March 30, 2025 from $30.9 million recognized in the three months ended March 31, 2024. The decrease in net interest expense resulted primarily from an increase in interest income on higher cash balances.
Income taxes. Income tax expense increased to $94.1 million, a 24.1% effective tax rate, for the three months ended March 30, 2025 compared to an income tax expense of $52.1 million, a 22.9% effective tax rate, for the three months ended March 31, 2024. The increase in income tax expense resulted primarily from the increase in profit before income taxes.
Liquidity and Capital Resources
The following table presents our available sources of liquidity as of March 30, 2025:

Sources of Liquidity |  | Facility Amount |  | Amount Outstanding |  | Amount Available
|  | (In millions)
Cash and cash equivalents |  | $ | — |  |  | $ | — |  |  | $ | 2,066.8 |
Borrowing arrangements: |  |  |  |  |  |
U.S. Credit Facility(a) |  | 850.0 |  |  | — |  |  | 825.8 |
Mexico Credit Facility(b) |  | 54.0 |  |  | — |  |  | 54.0 |
Europe Credit Facility(c) |  | 194.1 |  |  | — |  |  | 194.1 |

(a)Availability under the U.S. Credit Facility is also reduced by our outstanding standby letters of credit. Standby letters of credit outstanding at March 30, 2025 totaled $24.2 million.
(b)The U.S. dollar-equivalent of the facility amount under the Mexico Credit Facility is $54.0 million (Mex$1.1 billion).
(c)The U.S. dollar-equivalent of the facility amount under the Europe Credit Facility is $194.1 million (£150 million).
On March 13, 2025, the Company declared a special dividend of $6.30 per share, to stockholders of record as of April 3, 2025. On April 17, 2025, the Company paid that special dividend from retained earnings of approximately $1.5 billion. The Company used cash on hand to fund the special cash dividend.
We expect cash flows from operations, combined with availability under our credit facilities, to provide sufficient liquidity to fund current obligations, projected working capital requirements, maturities of long-term debt and capital spending for at least the next twelve months.
36

Historical Flow of Funds

Cash Flows from Operating Activities |  | Three Months Ended
|  | March 30, 2025 |  | March 31, 2024
|  | (In millions)
Net income |  | $ | 296.3 |  |  | $ | 174.9 |
Net noncash expenses |  | 103.8 |  |  | 127.3 |
Changes in operating assets and liabilities: |  |  |  |
Trade accounts and other receivables |  | (91.5) |  |  | 72.4 |
Inventories |  | (64.2) |  |  | 114.5 |
Prepaid expenses and other current assets |  | (44.0) |  |  | (27.6) |
Accounts payable, accrued expenses and other current liabilities |  | (118.7) |  |  | (212.8) |
Income taxes |  | 51.9 |  |  | 35.8 |
Long-term pension and other postretirement obligations |  | (1.4) |  |  | (1.3) |
Other operating assets and liabilities |  | (5.3) |  |  | (12.2) |
Cash provided by operating activities |  | $ | 126.9 |  |  | $ | 271.0 |

Net Noncash Expenses
Items necessary to reconcile from net income to cash flow provided by operating activities included net noncash expenses of $103.8 million for the three months ended March 30, 2025. Net noncash expense items included depreciation and amortization of $104.5 million, deferred income tax benefit of $11.0 million, stock-based compensation costs of $7.0 million, loan cost amortization of $1.2 million, losses on property disposals of $0.9 million, asset impairment of $0.6 million, accretion of discounts related to Senior Notes of $0.6 million, and gain on early extinguishment of debt recognized as component of interest expense of $0.1 million. Other net noncash items were immaterial.
Items necessary to reconcile from net income to cash flow provided by operating activities included net noncash expenses of $127.3 million for the three months ended March 31, 2024. Net noncash expense items included depreciation and amortization of $103.4 million, deferred income tax expense of $15.5 million, stock-based compensation costs of $4.7 million, losses on property disposals of $1.8 million, loan cost amortization of $1.3 million, and accretion of discounts related to Senior Notes of $0.6 million. Other net noncash items were immaterial.
Changes in Operating Assets and Liabilities
The change in trade accounts and other receivables represented a $91.5 million use of cash related to operating activities for the three months ended March 30, 2025. This change resulted from an increase in trade accounts receivable primarily due to an increase in sales from more favorable market pricing and a decrease in the use of our discounted accounts receivable program. The change in trade accounts and other receivables represented a $72.4 million source of cash related to operating activities for the three months ended March 31, 2024. This change primarily resulted from a decrease in trade accounts receivable and receivables from insurance recoveries.
The change in inventories represented a $64.2 million use of cash related to operating activities for the three months ended March 30, 2025. This change resulted primarily from increased input costs and an increase in inventories after higher seasonal sales in the fourth quarter of 2024. The change in inventories represented a $114.5 million source of cash related to operating activities for the three months ended March 31, 2024. This change resulted primarily from decreased raw materials and work-in-process and finished goods inventories primarily due to lower feed ingredient costs.
The change in prepaid expenses and other current assets represented a $44.0 million use of cash related to operating activities for the three months ended March 30, 2025. This change resulted primarily from an increase in prepaid indirect taxes in our Mexico and Europe reportable segments. The change in prepaid expenses and other current assets represented a $27.6 million use of cash related to operating activities for the three months ended March 31, 2024. This change resulted primarily from an increase in prepaid indirect taxes in our Mexico and Europe reportable segments.
The change in accounts payable, accrued expenses and other current liabilities represented a $118.7 million use of cash related to operating activities for the three months ended March 30, 2025. This change resulted primarily from the payment of incentive compensation accrued for in 2024. The change in accounts payable, accrued expenses and other current liabilities represented a $212.8 million use of cash related to operating activities for the three months ended March 31, 2024. This change resulted primarily from timing of payments to our suppliers and a reduction in grain input costs.
37

The change in income taxes, which includes income taxes receivable, income taxes payable, deferred tax assets, deferred tax liabilities, reserves for uncertain tax positions, and the tax components within accumulated other comprehensive loss, represented a $51.9 million and $35.8 million source of cash for the three months ended March 30, 2025 and March 31, 2024, respectively.

Cash Flows from Investing Activities |  | Three Months Ended
|  | March 30, 2025 |  | March 31, 2024
|  | (In millions)
Acquisitions of property, plant and equipment |  | $ | (98.3) |  |  | $ | (108.4) |
Proceeds from property disposals |  | 1.2 |  |  | 2.2 |
Cash used in investing activities |  | $ | (97.1) |  |  | $ | (106.2) |

Capital expenditures were incurred primarily to improve operational efficiencies, system enhancement projects, and reduce costs for the three months ended March 30, 2025.
Capital expenditures were incurred for growth projects, such as the South Georgia protein conversion plant, and to improve operational efficiencies, system enhancement projects, and reduce costs for the three months ended March 31, 2024.

Cash Flows from Financing Activities |  | Three Months Ended
|  | March 30, 2025 |  | March 31, 2024
|  | (In millions)
Payments on revolving line of credit, long-term borrowings and finance lease obligations |  | $ | (3.6) |  |  | $ | (0.1) |
Proceeds from contribution of capital under Tax Sharing Agreement with JBS USA Holdings |  | — |  |  | 1.4 |
Cash provided by (used in) financing activities |  | $ | (3.6) |  |  | $ | 1.3 |

Payments on revolving line of credit, long-term borrowings and finance lease obligations during the three months ended March 30, 2025, are primarily related to open market repurchases of outstanding senior notes.
The proceeds from the Tax Sharing Agreement with JBS USA Holdings were a payment of net tax incurred during the tax year 2023. Payments on revolving line of credit, long-term borrowings and finance lease obligations are primarily related to payments on finance lease obligations.
Long-Term Debt and Other Borrowing Arrangements
Our long-term debt and other borrowing arrangements consist of senior notes, revolving credit facilities and other term loan agreements. For a description, refer to “Note 12. Debt.”
Reconciliation of Net Income to EBITDA and Adjusted EBITDA
“EBITDA” is defined as the sum of net income (loss) plus interest, taxes, depreciation and amortization. “Adjusted EBITDA” is calculated by adding to EBITDA certain items of expense and deducting from EBITDA certain items of income that we believe are not indicative of our ongoing operating performance consisting of: (1) foreign currency transaction gains, (2) costs related to litigation settlements, (3) restructuring activities losses, and (4) net income attributable to noncontrolling interests. EBITDA is presented because it is used by us and we believe it is frequently used by securities analysts, investors and other interested parties, in addition to and not in lieu of results prepared in conformity with U.S. GAAP, to compare the performance of companies. We believe investors would be interested in our Adjusted EBITDA because this is how our management analyzes EBITDA applicable to continuing operations. We also believe that Adjusted EBITDA, in combination with our financial results calculated in accordance with U.S. GAAP, provides investors with additional perspective regarding the impact of certain significant items on EBITDA and facilitates a more direct comparison of our performance with our competitors. EBITDA and Adjusted EBITDA are not measurements of financial performance under U.S. GAAP. EBITDA and Adjusted EBITDA have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under U.S. GAAP. Some of the limitations of these measures are:
•They do not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
•They do not reflect changes in, or cash requirements for, our working capital needs;
•They do not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;
38

•Although depreciation and amortization are noncash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements;
•They are not adjusted for all noncash income or expense items that are reflected in our statements of cash flows;
•EBITDA does not reflect the impact of earnings or charges attributable to noncontrolling interests;
•They do not reflect the impact of earnings or charges resulting from matters we consider to not be indicative of our ongoing operations; and
•They do not reflect limitations on or costs related to transferring earnings from our subsidiaries to us.
In addition, other companies in our industry may calculate these measures differently than we do, limiting their usefulness as a comparative measure. Because of these limitations, EBITDA and Adjusted EBITDA should not be considered as an alternative to net income as indicators of our operating performance or any other measures of performance derived in accordance with U.S. GAAP. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using EBITDA and Adjusted EBITDA only on a supplemental basis.

| Three Months Ended
| March 30, 2025
| (In thousands)
Net income | $ | 296,343 |
Add: |
Interest expense, net | 16,785 |
Income tax expense | 94,099 |
Depreciation and amortization | 104,518 |
EBITDA | 511,745 |
Add: |
Restructuring activities losses | 16,612 |
Litigation settlements | 7,250 |
Minus: |
Foreign currency transaction gains | 2,053 |
Net income attributable to noncontrolling interest | 310 |
Adjusted EBITDA | $ | 533,244 |

39

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market Risk-Sensitive Instruments and Positions
The risk inherent in our market risk-sensitive instruments and positions is primarily the potential loss arising from adverse changes in commodity prices, foreign currency exchange rates, interest rates and the credit quality of available-for-sale securities as discussed below. The sensitivity analyses presented do not consider the effects that such adverse changes may have on overall economic activity, nor do they consider additional actions our management may take to mitigate our exposure to such changes. Actual results may differ from those described below.
Commodity Prices
We purchase certain commodities, primarily corn, soybean meal, soybean oil, and wheat, for use as ingredients in the feed we either sell commercially or consume in our live operations. As a result, our earnings are affected by changes in the price and availability of such feed ingredients. We have from time to time attempted to minimize our exposure to the changing price and availability of such feed ingredients using various techniques, including, but not limited to, (1) executing purchase agreements with suppliers for future physical delivery of feed ingredients at established prices and (2) purchasing or selling derivative financial instruments such as futures and options.
For this sensitivity analysis, market risk is estimated as a hypothetical 10% increase in the weighted-average cost of our primary feed ingredients as of the periods presented. The impact of this fluctuation, if realized, could be mitigated by related commodity hedging activity. However, fluctuations greater than 10% could occur.

| Three Months Ended March 30, 2025
| Amount |  | Impact of 10% Increase in Feed Ingredient Prices
| (In thousands)
Feed ingredient purchases(a) | $ | 861,957 |  |  | $ | 86,196 |
Feed ingredient inventory(b) | 174,979 |  |  | 17,498 |

(a)Based on our feed consumption, a 10% increase in the price of our feed ingredient purchases would have increased cost of sales for the three months ended March 30, 2025.
(b)A 10% increase in ending feed ingredient prices would have increased inventories as of March 30, 2025.

| March 30, 2025
| Amount |  | Impact of 10% Increase in Commodity Prices
| (In thousands)
Net commodity derivative assets(a) | $ | 19,135 |  |  | $ | 1,914 |

(a)We purchase commodity derivative financial instruments, specifically exchange-traded futures and options, in an attempt to mitigate price risk related to our anticipated consumption of commodity inputs for the next 12 months. A 10% increase in corn, soybean meal, soybean oil and wheat prices would have resulted in an increase in the fair value of our net commodity derivative asset position, including margin cash, as of March 30, 2025.
Interest Rates
Fixed-rate debt. Market risk for fixed-rate debt is estimated as the potential decrease in fair value resulting from a hypothetical increase in interest rates of 10%. Using a discounted cash flow analysis, a hypothetical 10% increase in interest rates would have decreased the fair value of our fixed-rate debt by $98.3 million as of March 30, 2025.
Foreign Currency
Mexico Foreign Investments
We are exposed to foreign exchange-related variability of investments and earnings from our Mexican subsidiaries. Foreign currency market risk is the possibility that our financial results or financial position could be better or worse than planned because of changes in foreign currency exchange rates. For this sensitivity analysis, market risk is estimated as a hypothetical 10% change in exchange rates used to convert Mexican peso to U.S. dollars, and the effect of this change on our Mexican foreign investments.
Net Assets. As of March 30, 2025, our Mexican subsidiaries that are denominated in Mexican peso had net assets of $826.3 million. A 10% weakening in Mexican peso against the U.S. dollar exchange rate would cause a decrease in the net
40

assets of our Mexican subsidiaries by $75.1 million. A 10% strengthening in the Mexican peso against the U.S dollar exchange rate would cause an increase in the net assets of our Mexican subsidiaries of $91.8 million.
We are also exposed to the effect of potential currency exchange rate fluctuations to the extent that amounts are repatriated from Mexico to the U.S. The Mexican peso exchange rate can directly and indirectly impact our financial condition and results of operations.
Europe Foreign Investments
We are exposed to foreign exchange-related variability of investments and earnings from our Europe subsidiaries. Foreign currency market risk is the possibility that our financial results or financial position could be better or worse than planned because of changes in foreign currency exchange rates. For this sensitivity analysis, market risk is estimated as a hypothetical 10% change in exchange rates used to convert British pound and euro to U.S. dollars, and the effect of this change on our Europe foreign investments.
Net Assets. As of March 30, 2025, our Europe subsidiaries that are denominated in British pounds had net assets of $842.0 million. A 10% weakening in British pound against the U.S. dollar exchange rate would cause a decrease in the net assets of our Europe subsidiaries by $76.5 million. A 10% strengthening in the British pound against the U.S dollar exchange rate would cause an increase in the net assets of our Europe subsidiaries of $93.6 million.
Cash flow hedging transactions. We periodically enter into foreign currency forward contracts, which are designated and qualify as cash flow hedges, to hedge foreign currency risk on a portion of sales generated and purchases made by our Europe reportable segment. A 10% weakening or strengthening of the U.S. dollar against the British pound and U.S. dollar against the euro would result in immaterial changes in the fair values of these derivative instruments. No assurance can be given as to how future movements in currency rates could affect our future financial condition or results of operations.
Quality of Investments
Certain retirement plans that we sponsor invest in a variety of financial instruments. We have analyzed our portfolios of investments, and to the best of our knowledge, none of our investments, including money market funds units, commercial paper and municipal securities, have been downgraded, and neither we nor any fund in which we participate hold significant amounts of structured investment vehicles, auction rate securities, collateralized debt obligations, credit derivatives, hedge funds investments, fund of funds investments or perpetual preferred securities. Certain postretirement funds in which we participate hold significant amounts of mortgage-backed securities. However, none of the mortgages collateralizing these securities are considered subprime.
Impact of Inflation
The U.S., Mexico, and most of Europe continue to experience inflation at above-historical levels, though to a lesser degree than in the prior year. None of the locations in which we operate are experiencing hyperinflation. We have responded to these inflationary challenges by continuing negotiations with customers to recoup the extraordinary costs we have experienced. We also continue to focus on operational initiatives that aim to deliver labor efficiencies, better agricultural performance and improved yields.
Forward Looking Statements
Certain written and oral statements made by our Company and subsidiaries of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made herein, in our other filings with the SEC, in press releases, and in certain other oral and written presentations. Statements of our intentions, beliefs, expectations or predictions for the future, denoted by the words “anticipate,” “believe,” “estimate,” “expect,” “project,” “plan,” “imply,” “intend,” “should,” “foresee” and similar expressions, are forward-looking statements that reflect our current views about future events and are subject to risks, uncertainties and assumptions. Such risks, uncertainties and assumptions include the following:
•Matters affecting the chicken and pork industries generally, including fluctuations in the commodity prices of feed ingredients, pigs and chicken;
•Our ability to maintain contracts that are critical to our operations;
•Our ability to retain management and other key individuals;
41

•Outbreaks of avian influenza or other diseases, either in our own flock or elsewhere, affecting our ability to conduct our operations and/or demand for our poultry products;
•Contamination of our products, which has previously and can in the future lead to product liability claims (for which insurance coverage is expensive, limited and potentially inadequate) and product recalls;
•Media campaigns related to food production, regulatory and customer focus on sustainability, and recent increased focus and attention by the U.S. government on market dynamics;
•Changes in laws or regulations affecting our operations or the application or enforcement thereof, including those relating to climate change, immigration and anti-corruption;
•Competitive factors, inflation and pricing pressures, customer consolidation or the loss of one or more of our largest customers;
•Inability to consummate, or effectively integrate, any acquisition or to realize the associated anticipated cost savings and operating synergies;
•Currency exchange rate fluctuations, developments relating to tariffs and other international trade actions, trade barriers, exchange controls, expropriation and other risks associated with foreign segments;
•Restrictions imposed by, and as a result of, Pilgrim’s leverage;
•Disruptions in international markets and distribution channels for various reasons, including, but not limited to, the ongoing Russia-Ukraine war;
•The impact of cyber-attacks, natural disasters, power losses, unauthorized access, telecommunication failures, and other problems on our information systems;
•Our ability to maintain favorable labor relations with our employees and our compliance with labor laws;
•Extreme weather or natural disasters;
•The impact of uncertainties in litigation; and
•Other risks described herein and under “Part I—Item 1A—Risk Factors” in our 2024 Annual Report.
Actual results could differ materially from those projected in these forward-looking statements as a result of these factors, among others, many of which are beyond our control.
The Company’s forward-looking statements speak only as of the date of this report or as of the date they are made. In making these statements, we are not undertaking, and specifically decline to undertake, any obligation to address or update each or any factor in future filings or communications regarding our business or results, and we are not undertaking to address how any of these factors may have caused changes to information contained in previous filings or communications. Although we have attempted to list comprehensively these important cautionary risk factors, we must caution investors and others that other factors may in the future prove to be important and affect our business or results of operations.
42

ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), “disclosure controls and procedures” means controls and other procedures that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
As of March 30, 2025, the Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation and subject to the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, as of March 30, 2025, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information we are required to disclose in our reports filed with the SEC is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
The Company’s management, including the Chief Executive Officer and Chief Financial Officer, identified no change in the Company’s internal control over financial reporting that occurred during the three months ended March 30, 2025 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
During 2024, the Company completed the first phase of a multi-year implementation of an enterprise resource planning (“ERP”) system. The implementation did not materially affect our internal control over financial reporting during the three months ended March 30, 2025. The second phase of the implementation was completed on April 21, 2025 and we do not expect any material effects to our internal control over financial reporting throughout the remainder of the implementation period.
43

Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information required with respect to this item can be found in Part I, Item 1, Notes to Consolidated Financial Statements, “Note 19. Commitments and Contingencies” in this quarterly report and is incorporated by reference into this Item 1.
ITEM 1A. RISK FACTORS
For a discussion of our potential risks and uncertainties, please see “Part I—Item 1A—Risk Factors” and “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2024 Annual Report and “Part I—Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” herein, in each case as updated by the Company’s periodic filings with the SEC. There have been no material changes to the risk factors previously disclosed in our 2024 Annual Report.
ITEM 5. OTHER INFORMATION
None of the Company’s directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as such terms are defined in Item 408 of Regulation S-K) during the Company’s fiscal quarter ended March 30, 2025.
ITEM 6. EXHIBITS

Exhibit No. |  | Description
3.1 |  | Amended and Restated Certificate of Incorporation of the Company. (incorporated by reference from Exhibit 3.1 of the Company's Current Form 8-K (No. 001-09273) filed on May 3, 2021).
3.2 |  | Amended and Restated Corporate Bylaws of the Company. (incorporated by reference from Exhibit 3.2 of the Company's Current Form 8-K (No. 001-09273) filed on May 3, 2021).
10.1 |  | Tax Sharing Agreement by and among JBS USA Food Company Holdings and Pilgrim’s Pride Corporation, dated as of December 30, 2024 (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 30, 2024).
31.1 |  | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2 |  | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1 |  | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2 |  | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS |  | Inline XBRL Instance Document
101.SCH |  | Inline XBRL Taxonomy Extension Schema
101.CAL |  | Inline XBRL Taxonomy Extension Calculation
101.DEF |  | Inline XBRL Taxonomy Extension Definition
101.LAB |  | Inline XBRL Taxonomy Extension Label
101.PRE |  | Inline XBRL Taxonomy Extension Presentation
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* |  | Filed herewith.
** |  | Furnished herewith.

44

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | PILGRIM’S PRIDE CORPORATION |
Date: April 30, 2025 |  | /s/ Matthew Galvanoni |
|  | Matthew Galvanoni |
|  | Chief Financial Officer and Chief Accounting Officer |
|  | (Principal Financial Officer, Principal Accounting Officer and Authorized Signatory) |

45